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ABSTRACT 
 
 
 The unique properties of gold nanoparticles make them ideal candidates 
for applications in biology and medicine. Gold nanoparticles have enhanced 
optical properties and their surface chemistry can be controlled, creating 
opportunities for their use in a variety of roles including genomics, clinical 
chemistry, photothermolysis of cancer cells and tumors, targeted drug delivery, 
and optical bioimaging of cells and tissues. Recently, there has been tremendous 
effort by scientists around the world to investigate these applications. However, 
before gold nanoparticles make it to the point of care, there is a need to better 
understand and control their impact on biological systems. Herein, the interaction 
of gold nanoparticles with proteins and cells were investigated. Their nonlinear 
optical signals for improve imaging in tissue was studied. Synthetic approaches 
to improve biocompatibility of the gold nanorods were achieved.  
 Protein-gold nanoparticle interactions, in particularly gold nanorods, are 
investigated using different analytical techniques. When nanoparticles are 
injected in a biological environment, proteins will adsorb instantaneously to their 
surfaces, creating a protein corona around the nanomaterial. Different proteins 
will have different affinities for the nanoparticle’s surface based on their surface 
chemistry, and protein conformation might change upon adsorption, which can 
lead to changes in cellular functions. Herein, the interaction of different gold 
nanorods based on their size and surface charge with bovine serum albumin was 
investigated using different analytical techniques to obtain thermodynamic and 
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kinetic information. Techniques which do not require harsh separation methods 
such has high velocity centrifugation are preferable in order to prevent protein 
desorption. Steady-state fluorescence based on the gold nanorod quenching 
effect on protein fluorescence was investigated; however, gold nanorod optical 
interference, led to overestimation of binding affinities. As an independent and 
comparative method, affinity capillary electrophoresis was used as a technique to 
calculate binding affinities was studied. This technique does not suffer from GNR 
optical interference establishing capillary electrophoresis as a robust method to 
probe these interactions. In addition, fluorescence correlation spectroscopy was 
also studied, as a robust technique to probe the kinetic of nanoparticle-protein 
interactions if the optical interference of the gold nanorod can be efficiently 
subtracted.  
 Enhanced nanoparticle targeting of the malignant prostate cancer cells 
(PC-3), overexpressing EphA2 receptors was investigated. Gold nanorods were 
functionalized with the YSA homing peptide via a robust layer-by-layer coating 
approach. A measured increase in uptake of the YSA-GNRs, compared to a 
reversed control (Rev-YSA-GNRs), was observed. The effect of the YSA-GNRs 
on PC-3 cell proliferation after interaction with the EphA2 receptors was also 
studied; however, it remains questionable whether or not the YSA-GNRs alone 
can be used as a therapeutic agent.  
 To enhance the use of gold nanorods as contrast agents in tissue 
imaging, the two-photon luminescence of gold nanorods was probed under 
varying laser pulse shape and polarizations. The intensity of the two-photon 
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signal from the nanorods was found to vary with these parameters, suggesting 
the possibility of improved control in tissue imaging by limiting 
photodamage/deformation and excess gold nanorod signal. However, there is a 
need to develop a better approach to align the nanorods at different angles to 
better study their response under different incoming light. 
 Lastly, the biocompatibility of the gold nanorods was enhanced. The 
concentration of cetyltrimethylammonium bromide surfactant used in the 
synthesis step was reduced to 20% of its original concentration by compensating 
the reaction with bromide salt. This study also highlights the importance of the 
bromide ions in the growth of the gold nanorods.   
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CHAPTER 1 
INTRODUCTION AND DISSERTATION OVERVIEW 
 
 
1.1 Optical Properties and Applications of Gold Nanoparticles 
 Gold nanoparticles (diameter 5-200 nm) have been known for centuries 
and were first used as pigments in the staining of glass.1 Michael Faraday was 
the first to chemically synthesize solutions of colloidal gold in 1857.2 However, it 
was not until Richard Feynman gave his talk “There’s Plenty of Room at the 
Bottom” in 1959 that nanotechnology revolution began.3 Recently, gold 
nanoparticles have been the subject of extensive research. This great interest 
stems from the unique interaction of this nanoscale material with light. Electrons 
in the conduction band of the gold nanoparticles are excited by incoming 
electromagnetic radiation, causing them to oscillate. When the frequency of the 
incoming light matches the frequency of the oscillating electrons, coherence is 
attained and large optical extinction is observed (optical absorption and 
scattering). This is known as a resonance condition and is termed the localized 
surface plasmon resonance (LSPR).4 The LSPR of gold nanoparticles occurs in 
the visible-near infrared region of the electromagnetic spectra and it depends on 
their size and shape.5  
 Mie theory was the first theoretical framework to describe the optical 
absorption/scattering from small spherical nanoparticle upon interaction with light 
as a function of size, light wavelength, and dielectric constant of both medium 
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and the metallic core using the Maxwell’s equations.4 Mie’s work provided 
significant insight into the optical properties of these nanomaterials. Recently, 
anisotropically shaped gold nanoparticles have raised significant interest due to 
their superior optical properties compare to spherical nanoparticles. This includes 
shapes such as nanorods,6 nanocages,7 and nanoshells.8 In the research 
covered in this dissertation, gold nanorods and gold nanospheres are employed.  
 The optical properties of gold nanorods are different from their spherical 
counterparts since there is a shift in shape from isotropy to anisotropy.2 When 
LSPR is induced by light isotropic gold nanospheres exhibit one LSPR. However, 
gold nanorods show two plasmon oscillations along each of the two axes of the 
rod particle. The oscillation along the short axis occurs at shorter wavelength 
(~520nm) and is called the transverse plasmon peak. The oscillation along the 
long axis of the nanorod occurs at longer wavelength and is called the 
longitudinal plasmon peak (Figure 1.1). The longitudinal peak can be tuned in the 
vis-NIR region of the spectrum since it is sensitive to changes in size, refractive 
index of the medium, and aggregation state of the nanorods.9,10 This effect 
makes gold nanorods very interesting for application in sensing,11 imaging,1 and 
therapeutics.12   
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Figure 1.1. Schematic of localized surface plasmon resonance of spherical gold 
nanoparticles (Top image) and gold nanorods (Bottom image) and UV-Vis 
spectra signature. Black oscillating lines represent incoming electromagnetic 
radiation. (+) and (-) signs represent varying dipole at the gold nanoparticles 
surface due to electrons oscillation.  
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 With an extinction cross-section on the order of 109 cm-1 M-1, gold 
nanorods have molar extinction coefficient at least four order of magnitude larger 
than any organic chromophores, making them excellent absorber/scatterer in the 
vis-NIR region of the spectrum.4,13 Due to the sensitivity of the longitudinal 
plasmon peak to changes in the environment of the gold nanorods, these 
particles have been used to develop sensing platforms.1 For example, adsorption 
of analytes to the surface of the gold nanorods induce changes in the total 
dielectric constant of the surrounding and causes significant wavelength shift in 
the UV-Vis spectra of the gold nanorods.1  
 Furthermore, metallic nanoparticles including gold, enhance the inelastic 
scattering of light from molecules in close proximity to their surface.14 When gold 
nanorods are irradiated with light at the LSPR, the oscillating electrons in the 
conduction band induce an enhanced electrical field around the nanoparticles.14 
Molecules located in proximity to the surface of the nanoparticle will be exposed 
to this enhanced electric field and will experience enhanced Raman scattering, 
since Raman scattering is a function of the electrical field.11,14 This phenomenon 
is known as surface enhanced Raman scattering (SERS) and provides an 
efficient and sensitive sensing platform for single molecule detection.11,14,15 
Furthermore, during the localized surface plasmon oscillation, the excited 
electrons release their energy by emitting heat in to the surrounding medium. 
This decay of energy into the form of heat can be employed in photothermal 
therapy, which is the destruction of malignant cells and tissues in vivo.5 Table 1.1 
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summarizes the physical events that arise from LSPR and their respective 
applications.  
 
Table 1.1. Summary of the physical events that occur upon gold nanorods 
irradiation with light and their corresponding applications 
Physical Event Application 
Light absorption in the vis-NIR Sensing via changes in local refractive 
index, aggregation, and de-aggregation 
Light scattering in the vis-NIR Imaging and tracking  
Enhanced local electrical field Surface enhanced Raman scattering 
Light absorption leading to heat Photothermal Therapy  
 
1.2 Synthesis of Gold Nanoparticles  
  The preparation of gold nanoparticles has been studied extensively. 
Michael Faraday was the first one to report the chemical synthesis of these 
particles in the form of spheres in 1857.16 More recently, gold nanoparticles of 
different diameters and capping agents have been prepared.17,18 The most 
common methods involve the use of citrate as both a reducing and capping 
agent known as the Turkevich method.19 Murphy et al, have shown that 
cetyltrimethylammonium bromide (CTAB) capped gold nanoparticles with 
diameter ranging from 5-40 nm can be prepared using 3.5 nm citrate seeds.18 
The work covered in this dissertation employed mostly CTAB capped gold 
nanoparticles of ~20 nm diameters.   
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Recently, rod-shaped particles have received an increased interest due to 
their superior optical properties. However, the synthesis of gold nanorods 
represents a more complicated challenge due to the need to control the 
assembly of building units at the atomic level.  A variety of techniques have been 
employed for the preparation of these particles such as electrochemical 
synthesis, UV-photothermal reduction, lithographic fabrication, and template-
assisted synthesis.6,20-22 However, a seed-mediated synthesis using wet 
chemicals has been shown to be the most efficient way to prepare the gold 
nanorods and is employed by in our laboratory.6,20-22  
 The wet chemical seed-mediated approach first described by Murphy et 
al, has become a practical route in preparing gold nanorods of different aspect 
ratios (length divided by width)  (Figure 1.2). The synthesis of the gold nanorods 
by this method is performed in water at room temperature. There is no need for 
harsh solvents and the time scale is close to two hours.6,20,23 These 
characteristics make the preparation of the gold nanorods extremely accessible 
with a yield of more than 90% on a per particle base.23 Aspect ratios from 1 to 5 
are obtained by varying the concentration of specific reagents.6,20 The synthesis 
of gold nanorods involves a two-step procedure. First, seeds of about ~1.5 nm 
are prepared in the presence of cetyltrimethylammonium bromide (CTAB) which 
act as a capping agent. To make those seeds, gold salt (HAuCl4) is reduced with 
a strong reducing agent (NaBH4). After preparing the seeds, they are then added 
to a “growth solution” which contains CTAB, Au3+ (HAuCl4), ascorbic acid as a 
weak reducing agent (Au3+ à Au1+), and silver ions (Ag1+) from silver nitrate. 
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After a 6 to 12 hour period of incubation, gold nanorods solution of varying colors 
are obtained based on the final dimensions (Figure 1.3) 
 The reagents used in the seed-mediated approach for the preparation of 
gold nanorods play specific roles. Varying the ingredients and their concentration 
will also alter their shape, length, monodispersity, and stability.6,20,24 The 
surfactant, CTAB, is essential in the formation of nanorods.25-27 The details of its 
structure, such as the length of its carbon chain, the concentration used, and the 
purity of the CTAB used can affect the growth process. Additionally, the presence 
of silver ions at low concentrations plays an important role in the monodispersity 
and high yield of gold nanorods.13 The amount of added Ag ions will determine 
the aspect ratio of the particles. The silver concentration is varied slightly to 
determine to final dimensions of the nanorods up to an aspect ratio of ~5.  
 The growth mechanism of gold nanorods in the presence of silver ions 
was investigated using high-resolution transmission electron microscopic 
analysis (TEM).28 The CTAB capped seeds prepared have been shown to be 
single crystals and the silver-assisted gold nanorods to be enclosed by eight 
identical high-index crystalline facets.  They have {100} and {110} 
crystallographic directions pointing toward lateral edges with {250} faces joining 
them.28 The tip facets are all {110} and {111} types. The presence of silver ions at 
the surface of the gold nanorods has also been proven using inductively coupled 
plasma mass spectrometry of the purified particles.13 From these results, a 
mechanism has been proposed for gold nanorod formation. Silver ions undergo 
under potential deposition (UPD) and are reduced to Ag0. The rate of silver UPD 
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at the {110} facets is higher compared to {100} facets, thus growth is promoted in 
one direction.13 Furthermore, after silver deposition, CTAB binds strongly to the 
silver-passivated surfaces, preventing gold deposition on the sides.13,29  
 Higher aspect ratio gold nanorods has also been prepared. The approach 
to prepare longer nanorods varies slightly compare to aspect ratio 1-5.30 It 
involves a controlling the ratio of seed to metal salt using a 3-step seeding 
method. This approach ensures the presence of high concentrations of gold salt 
and a limited amount of seed to favor the growth of longer particles. Gold 
nanorods of aspect ratio ~18 have been prepared using this method.30  
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Figure 1.2. Illustration of the wet chemical seed mediated method to prepare 
gold nanorods for a 100 mL batch. Step 1 (Panel A) involves preparing the CTAB 
capped seed solution, NaBH4 is used as a strong reducing agent. In parallel, a 
growth solution is prepared (panel B). Step 2 involves using the seed from step 1 
along with the growth solution to prepare the gold nanorod solution (Panel C).  A 
3-step protocol is used to prepare long gold nanorods by controlling the ratio of 
seed to gold salt. Long gold nanorods of aspect ratio 18 are obtained following 
this protocol (Panel D).  However, to prepare shorter gold nanorods, a simpler 1-
step protocol is used in the presence of silver ions yielding gold nanorods of 
aspect ratio (1-5) based on amount of silver ions added (Panel E). Ascorbic acid 
was used as a weak reducing agent in both cases.  
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Figure 1.3. Transmission electron microscopy images and photographs of gold 
nanorods solutions of different aspect ratios (Panel A-E) prepared using wet 
chemical seed-mediated method with different silver ions concentration. Scale 
bar from left to right: 50, 100, 100, 200, and 200 nm. Corresponding UV-visible 
spectra are shown (F). A change in color is observed with increasing aspect 
ratios (G).  
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1.3 Gold Nanoparticles in Biology 
 Due to the unique properties of gold nanoparticles, many potential 
applications are being investigated in biology, including biomedical sensors, drug 
delivery vehicles, and nanotherapeutics.10,31  
Nanoparticles possess the so-called enhanced permeability and retention 
effects (EPR) which causes them to accumulate in higher amounts in cancerous 
compare to healthy tissues due the leaky tumor blood vasculature.32,33 Moreover, 
nanomaterials have a high surface area, which increases drug-loading efficiency, 
resulting in enhanced drug solubility, stability, and pharmacokinetic parameters.34 
While gold nanoparticles possess both the EPR effect and a high surface area, 
similarly to most of the nanocarriers mentioned above, gold nanoparticles also 
have unique optical properties upon interaction with light. Gold is also one of the 
most chemically inert metals (in the bulk form) and it has a high electron density. 
These properties make gold nanomaterials excellent choices for biological 
applications. However, before this nanomaterial can be introduced into the 
biological system, scientists need to understand their level of toxicity, their 
interactions with biomolecules, their effect on cellular functions, and finally their 
fate in the biological system.  
Indeed, when used for drug delivery and cancer therapy applications, gold 
nanoparticles will be exposed to biological media prior to reaching the active 
site.35 Additionally, in vitro studies, which are done in cell culture, require the 
particles to be exposed to cellular growth media35. As several studies have 
shown, putting the nanoparticles in such environments will cause an immediate 
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adsorption of biomolecules (including proteins) to their surface as soon as they 
come into contact with biological media.34,36-40 Due to the high surface area of the 
nanoparticles, proteins adsorb abundantly to the surface of these particles 
creating a layer of more or less tightly bound proteins recently identified as the 
protein corona.37 As opposed to a covalently attached layer, the protein corona is 
dynamic and its composition is determined by the concentration and affinity of 
the large numbers of proteins present.36-40 The nature of adsorbed biomolecules 
is of great importance since they represent the observable layer around the 
nanoparticles that the cells “sees” and interacts with, and thus influences the 
toxicity, cellular uptake, pharmacokinetics, and immunogenicity of these 
nanomaterials.39,40 It has been shown that proteins from blood adsorb to the 
surface of nanoparticles and causes the fast elimination of these nanomaterials 
from the circulation by the reticuloendothelial system (RES).41 Antifouling 
molecules such as polyethylene glycol have been used to prevent protein 
adsorption to the surface of gold nanoparticles, thus enhancing their retention 
time in the circulatory system.  
There is a great need for a detailed understanding of the thermodynamics 
and kinetics of protein adsorption to nanoparticles. Experimental techniques, 
therefore, need to measure the protein corona composition and its changes over 
time. Spectroscopic techniques that follow changes in the LSPR bands have 
been used to infer interaction of different proteins with gold nanoparticles.42 
Fluorescence quenching in the presence of gold nanoparticles can also be used 
to determine the binding constants of proteins (that contain fluorescent residues) 
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as they adsorb to the nanoparticles (see chapter 2).43 A variety of other 
techniques have been used to investigate protein-nanoparticle interactions, such 
as isothermal titration calorimetry (ITC), quartz crystal microbalance (QCM), 
circular dichroism (CD), zeta potential analysis, gel electrophoresis, and mass 
spectrometry.37,42,44  
At this time, most publications have focused on protein-nanoparticle 
studies with spherical gold nanoparticles.43-45 However, there are emerging 
works focusing on gold nanorods.46,47 And so far, there has been a wide range of 
variation in binding constants calculation reported for protein-nanoparticles (104-
1010 M-1). This illustrates the need for a comprehensive study of the interactions 
of different proteins with a variety of gold nanoparticles using reliable analytical 
techniques. Such study will provide scientists with thermodynamic, kinetic, and 
conformational information that will help predict the interaction of the 
nanomaterials with cells.  
Nanoparticles are comparable in size to many biological molecules and 
subcellular components, which make possible the interactions of the particles 
within cellular compartments.48 It has already been shown that gold nanoparticles 
can enter mammalian cells.49 The localization of the nanoparticles in the cells 
depends on the surface chemistry of the nanoparticles. Different surface 
chemistries independent of the overall charge of the nanoparticles will result in 
variations of adsorbed proteins either in terms of protein type or conformation.  
Such variations will affect protein-mediated cellular uptake.36-40 The chemistry at 
the surface of the particles will also influence their toxicity level,49 thus it is 
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important to study biocompatibilities and calculate safe dosage levels. 
Additionally, the size of the nanomaterials will contribute to changes in particle 
uptake.  It has been shown that large particles (>500 nm) enter cells via 
phagocytosis while smaller particles (<100 nm) have been suggested to be 
uptaken via receptor-mediated endocytosis (RME).50 
In vitro cellular studies are essential for the understanding of nanoparticles 
effects on biology. However, scientists also need to investigate the fate of 
nanomaterials in whole organisms, in vivo.51,52 More information is needed on the 
pharmacology and pharmacokinetic of nanomaterials. Most studies up to this 
point have focused on measuring the biodistribution of gold nanoparticles in 
animal models.41,51,53,54 The ability of nanomaterials to decompose naturally is an 
important feature in biological applications. However, recent studies have shown 
that accumulation of gold nanoparticles in different organs do not have significant 
side effects. This signifies that these particles could remain in the body 
indefinitely with no negative impact.55,56   
Furthermore, there is a need for improved instrumentation that can not 
only track gold nanoparticle in vivo with extreme accuracy but also collect signal 
containing important information regarding the identity of the molecular 
environment around the gold nanoparticles with high degree of spatial resolution. 
Many research groups have put their attention on developing instrumentation 
sensitive enough to make use of the important optical properties of the gold 
nanoparticles. Techniques such as surface-enhanced Raman spectroscopy 
(SERS),57 photo-acoustic imaging (PAI),58 tomography,59 magnetic resonance 
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imaging (MRI),60 and two-photon luminescence (TPL)61 have proven to be 
successful optical techniques to image the gold particles in biological tissues.62  
 
 
1.4 Dissertation overview  
 Chapter 2 investigates the thermodynamics and kinetics involved in the 
adsorption of the model protein, bovine serum albumin, to the surface of gold 
nanoparticles with different shapes, sizes, and surface chemistries. To obtain 
such information, UV-Vis absorbance, steady-state fluorescence, and capillary 
electrophoresis were employed. Binding constants, binding cooperativity, and 
rate of adsorptions were calculated.    
 In Chapter 3, both the advantages and disadvantages of using certain 
spectroscopic technique to investigate the interaction of proteins with gold 
nanoparticles are explored. Both UV-visible absorbance and fluorescence 
spectroscopy are studied as method to study these types of interactions via 
separation of free versus bound protein. Furthermore, we probed the potential of 
both one-photon and two-photon fluorescence correlation spectroscopy to probe 
these interactions via direct measurements in solution.  
 Chapter 4 explores the polyelectrolyte layer-by-layer technique developed 
by the Murphy group to successfully functionalize gold nanorods with a mimetic 
peptide of the ephrinA1 ligand known as YSA to target cancer cells. The effect of 
the YSA-functionalized gold nanorods on prostate cancer cells (PC-3) was 
explored and compared to a reversed version of this peptide.  
	   16	  
  Gold nanorods have superior optical properties. Their enhanced 
electromagnetic field leads to strong nonlinear optical properties.  In chapter 5, 
the ability to control the two-photon luminescence signal of gold nanorods is 
investigated by varying the pulse shape and polarization of the incoming light for 
improve in vivo imaging.  
 To make the gold nanorods more biocompatible, Chapter 6 explores the 
synthesis of gold nanorods with lower amount of the surfactant 
cetyltrimethylammonium bromide (only 20% of the original amount) via the 
addition of bromide salt in to the synthesis recipe. The importance of the bromide 
ions is investigated and led to new insight regarding the mechanism of nanorod 
growth. This provides for gold nanorods with lower toxicity which is an important 
feat for the their use in biological applications.   
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CHAPTER 2 
NANOPARTICLE-PROTEIN INTERACTIONS: A THERMODYNAMIC AND 
KINETIC STUDY OF THE ADSORPTION OF BOVINE SERUM ALBUMIN TO 
GOLD NANOPARTICLE SURFACES 
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2.2 Introduction 
 In the last decade, gold nanoparticles (GNPs) have been the subject of 
much scientific attention due to their strong and tunable optical properties.1 
Chemists have made important progress in controlling GNP synthesis and the 
chemistry at their surface.2 Such progress has opened up a variety of 
applications for GNPs, which in the biological field ranges from chemical sensing 
to imaging to drug delivery.1-5 However, GNPs due to their nanoscale size have 
large surface areas, which can impair the function of living cells and organisms 
as biomolecules interact with their surface.6-11 This highlights the importance of 
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understanding the biological chemistry of gold nanomaterials in order to fully 
realize their promise in biomedicine. 
 The small size of nanoparticles allows them to enter cells.6,7 It has been 
established that different proteins will compete for the nanoparticle surface 
leading to a protein “corona”.8-12 The nature of the corona largely defines the 
biological identity of the nanoparticle. It is a dynamic system, therefore 
parameters such as binding affinities, rates of adsorption and desorption, are 
important in order to understand how nanoparticles are seen by cells as they 
travel in biological systems.13 Gathering thermodynamic and kinetic data on the 
interaction of proteins with nanoparticles is necessary to develop a framework 
that will allow for the prediction of how cellular systems will respond to the 
presence of nanoparticles based on their size, curvature, and charge.  
 For gold, a variety of different analytical techniques have been used to 
investigate protein-GNPs interactions. Spectroscopic techniques are used to 
determine binding affinity, ratio of protein to GNP, and mechanism of the 
adsorption of proteins to nanomaterial surfaces. Most published work employs 
optical techniques such as UV-Vis spectrophotometry,14,15 fluorescence,16-19 
circular dichroism14,20,21 and dynamic light scattering19,22,23 to probe the 
interaction of protein to nanomaterials. Those methods allow a direct 
measurement of the adsorption process without the need to separate free versus 
bound proteins. However, these methods suffer from gold nanoparticle spectral 
interference due to the high extinction coefficient of these gold nanomaterials 
especially gold nanorods (GNRs).24,25 
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 In this work, we investigate the thermodynamics and kinetics of a model 
protein, bovine serum albumin (BSA), adsorbing to the surface of GNPs using 
two independent and comparative analytical methods. GNPs were selected due 
to their interesting optical properties; their plasmonic peaks are sensitive to 
adsorption and can be used as a tool to unravel these interactions. Furthermore, 
their size, shape, and charge can be controlled using simple chemistries.26 
 Steady state fluorescence spectroscopy measurement takes advantage of 
the quenching capability of the GNPs. This method is suitable for our work since 
there is no need to separate free versus bound proteins. As a comparative 
method, we used affinity capillary electrophoresis (ACE). This method relies on 
the detection of shift in mobility of the GNPs in the presence of BSA as they 
travel through a capillary. It is an attractive technique since it allows the 
separation of free versus bound protein without the use of possibly harsh 
separation steps. The combination of these two independent techniques to probe 
the nanoparticle-protein complex allows us to determine with confidence the 
binding strength associated with the adsorption process.  
 This work sheds light into the advantages and disadvantages of using 
those two analytical methods to monitor the adsorption process. Furthermore, the 
contribution of electrostatic interaction during the binding process was studied by 
performing a salt titration experiments.  
 
2.3 Experimental section 
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2.3.1 Materials. Chloroauric acid (HAuCl4 .3H2O, 99.9%), sodium borohydride 
(NaBH4, 99%), silver nitrate (AgNO3, 99+%), cetyltrimethylammonium bromide 
(CTAB, 99%, Sigma Ultra), ascorbic acid (99+%), poly(acrylic acid, sodium salt), 
~15,000 g/mol, 35% wt in water, and poly(allylamine hydrochloride), ~15,000 
g/mol, were obtained from Sigma-Aldrich and used as received. Thiolated 
poly(ethylene glycol), 5,000 g/mol, was purchased from Nanocs. Bovine serum 
albumin (BSA) was purchased from Sigma Life Sciences and the protein from 
one batch was used in all experiments. Phosphate buffer saline (PBS) used was 
from Lonza. 3-(N-morpholino)propanesulfonic acid (MOPS) was purchased from 
Alfa Aesar.  All GNP solutions were prepared with purified 18 M.Ω water. 
Glassware was cleaned with aqua regia and rinsed thoroughly with deionized 
water.  
 
2.3.2 Instrumentations. Absorption spectra were taken on a Cary 500 scan UV-
vis-NIR spectrophotometer. Transmission electron microscopy (TEM) data were 
obtained with a Joel 2100 Cryo electron microscope operating at 200 kV. TEM 
grids were prepared by drop casting 10 µL of purified gold nanoparticle solution 
on the TEM grids and drying them in air. Zeta potential measurements were 
performed on a Brookhaven Zeta PALS instrument. Fluorescence measurements 
were performed on a Jobin Yvon Horiba Fluoromax-3 spectrophotometer.  A 
Hewlett-Packard 8453 spectrophotometer was used to collect kinetic data of the 
adsorption process at fast rates (10 spectra/s). Capillary electrophoresis 
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separation was performed on a P/ACE MDQ system (Beckman Coulter, 
Fullerton, CA, USA) equipped with a photodiode array detector.  
 
 
2.3.3 Synthesis of CTAB-Capped Gold Nanorods (Aspect Ratio = 3.5 and 
18). Gold nanorods were prepared using simple wet chemical method in the 
presence of the surface capping agent cetyltrimethylammonium bromide as 
previously described.2,27-29 A solution of 2.5 × 10-4 M HAuCl4 was prepared in 0.1 
M aqueous CTAB in a 50 mL centrifuge tube. NaBH4 (600 µL, of a 10 mM stock 
solution) was added to the gold/CTAB solution (10 mL) with vigorous stirring for 
10 min with the help of a stir bar. The resulting seed particles (~3 nm diameter) 
were used for the synthesis of both short and long gold nanorods. For the short 
gold nanorods (aspect ratio 3.5) the following were added, in order, to a conical 
flask: CTAB solution (95 mL of a 0.1 M stock solution), silver nitrate solution (1 
mL of a 10 mM stock solution), and HAuCl4  (5 mL of a 10 mM stock solution). An 
aqueous solution of ascorbic acid (0.55 mL of a 0.1 M stock solution) was then 
added with gentle mixing. Finally, the gold seed solution (0.12 mL) was added 
and mixed. The solution was left undisturbed overnight. The colored gold 
nanorod solution was purified by centrifugation (2X) to remove excess CTAB. 
The method yielded gold nanorods of length 54.0 ± 2.1 nm and width 15.9 ± 1.1 
nm.  
For the long gold nanorods (A.R. 18), a three-step seeding procedure was 
used.29 First, the following were added to two 15 mL centrifuge tubes: HAuCl4 
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(250 µL of 0.01 M stock solution) and aqueous CTAB (9 mL of 0.1 M CTAB stock 
solution) to each centrifuge tube. To these mixtures, ascorbic acid was added (50 
µL of 0.1 M stock solution) to each tube and mixed. In parallel, the following was 
added to a 200 mL conical flask: HAuCl4 (2.5 mL of 0.01 M stock solution and 
aqueous CTAB (90 mL of 0.1 M CTAB stock solution). To this flask, 0.5 mL of 
ascorbic acid (0.1M stock solution) was added.  To the first 15 mL centrifuge tube 
1 mL of seed was added, after 15 seconds 1 mL of this solution was added to the 
second centrifuge tube. After 30 seconds, the entire content of this solution was 
added to the 200 mL flask and the solution was gently mixed and stored for 
about 14 hrs. After 14 hours, the content of the flask was discarded leaving the 
long gold nanorods deposited at the bottom. These rods were suspended by 
washing the inside of the flask with purified water. Excess CTAB was removed 
through centrifugation The method yielded gold nanorods of length 342 ± 65 nm 
and width 21.1 ± 2.6 nm.  
 
2.3.4 Synthesis of 20 nm CTAB-Capped Nanospheres. 20 nm CTAB capped 
spheres were prepared using the method described previously.30 Citrate capped 
gold seed were prepared by reducing a solution of 0.5 mL HAuCl4 (0.01 M), 19 
mL of d. H2O, and 0.5 mL trisodium citrate (0.01 M) with 0.6 mL of 0.1 M sodium 
borohydride. A growth solution was prepared by mixing 6 g of solid CTAB (0.08 
M final concentration) with HAuCl4  (2.5 × 10-4 M final concentration) in purified 
water. The growth solution was heated until it turned clear orange. Two sets of 
50 mL conical flasks were labeled A and B. In flask A, 9 mL of growth solution 
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and 0.05 mL of 0.1 M ascorbic acid were mixed and 1 mL of the gold seed was 
added while stirring. The solution was stirred for 10 minutes giving a final deep 
red color. Particles prepared this way are about 8 nm in diameter and were used 
as seed to prepare 20 nm spheres. In flask B, 9 mL of growth solution was mixed 
with 0.05 mL of ascorbic acid and 1 mL from set A was added while stirring. The 
solution was stirred for 10 minutes and the final color of the solution was reddish 
brown. Excess CTAB was removed through centrifugation at 8000 rpm for 30 
minutes followed by redispersion in deionized water (twice). This method yielded 
gold nanospheres of diameter 21.5 ± 1.1 nm.  
 
2.3.5 Polyelectrolyte coating of gold nanoparticles. GNPs coated with 
different layers of polyelectrolytes were prepared by the layer-by-layer adsorption 
technique.31 Sodium polyacrylic acid (PAA) and poly (allylamine hydrochloride) 
(PAH), each with a molecular weight of approximately 15,000 g/mol, were used. 
200 µL of polyelectrolyte solution (10 mg/mL prepared in 10 mM NaCl solution) 
and 100 µL NaCl solution (10 mM) were added simultaneously to every 1 mL 
purified CTAB capped GNPs solution of different shape and size. The resulting 
solution was mixed gently and incubated overnight to allow for complete polymer 
coating.  To remove of the excess polyelectrolyte in solution, GNPs were 
centrifuged at 7000 rpm for 30 minutes and redispersed in water. GNPs were 
further dialyzed for 24 hours to ensure removal of excess reagents using 20K 
MWCO dialysis cassettes.  
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2.3.6. Preparation of Thiolated Polyethylene Glycol (PEG) Capped Gold 
Nanoparticles. As-synthesized gold nanoparticles of different shape and size 
were capped with a thiolated polyethylene glycol (mPEG-SH) through 
displacement of CTAB at the surface of the gold nanoparticles.32 A 100 mL 
aqueous solution of as-prepared gold nanoparticles was concentrated to 0.5 mL 
via centrifugation. Then, 2 mL of mPEG-SH (5000 g/mol) at concentration 20 
mg/mL was prepared and sonicated for 15 minutes. This solution was added 
dropwise under vigorous stirring to the CTAB-capped gold particle solution. The 
mixture was allowed to react for 12 hours. The PEG capped gold nanoparticles 
were purified by centrifugation at 7000 rpm for 30 minutes and redispersed in 
water. GNPs were further dialyzed for 24 hours to ensure removal of excess 
reagents using 20K MWCO dialysis cassettes. 
 
2.3.7 Steady State Fluorescence Quenching Measurements. For the 
fluorescence quenching measurements, the emission of BSA was measured at a 
constant concentration (0.66 µM) in the presence of an increasing concentration 
of gold nanoparticles (0-3 nM in particles). 3-morpholinopropane-1-sulfonic acid 
buffer (MOPS, 5 mM, pH 7) and nanopure water were used as solvents.  The 
nanoparticle-protein solutions were incubated overnight at 4°C to ensure 
equilibrium in Teflon vials. Before measuring the fluorescence of BSA, solutions 
were allowed to stand at room temperature for 30 minutes. The samples were 
then transferred to a quartz cuvette and their fluorescence spectra were acquired 
in the range of 300 to 460 nm when excited at 280 nm. Since the fluorescence of 
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BSA protein adsorbed to the surface of the GNPs is quenched, the observed 
fluorescence is due to the free BSA in the solution. The area under each 
fluorescence curve was integrated and used to measure the free BSA 
concentration using a standard calibration curve.  
 
2.3.8 Capillary Electrophoresis Measurements. A bare fused silica capillary 
with a 50 mm internal diameter and 360 µm outer diameter (Polymicro 
Technologies, Phoenix, AZ, USA) with an effective length of 20.0 cm and a total 
length of 30.2 cm was used for all separations. Capillaries were subject to the 
following flushing sequence daily: 1 M NaOH for 30 min at 69 kPa (10 psi), 
deionized water for 15 min at 69 kPa (10 psi), 15 min with methanol at 69 kPa 
(10 psi), deionized water for 15 min at 69 kPa (10 psi). Prior to each 
electrophoretic separation the separation capillary was flushed as follows: 1 M 
NaOH for 1 min at 69 kPa (10 psi), 1 min with methanol at 69 kPa (10 psi), 
deionized water for 2 min at 69 kPa (10 psi), and 3 min at 69 kPa (10 psi), 5mM 
MOPS. To prevent aggregation of the nanoparticles upon addition of the 
dimethylformamide neutral marker to the nanoparticle stock, serial injection was 
used. The dimethylformamide diluted in 5 mM MOPS was introduced first with a 
pressure of 3 kPa (0.5 psi) for 5 sec.  The nanoparticles were then injected using 
a pressure of 7 kPa (1 psi) for 4 sec.  When smaller injection volumes were used, 
the nanoparticles could not be detected. Separations were accomplished using 
normal polarity with an applied voltage of 6 kV (E = 200 V/cm) and 12 kV (E = 
400 V/cm) for neutral and negative nanoparticles, respectively.  Data collection 
	   33	  
and analysis were performed using 32 Karat Software version 5.0 (Beckman 
Coulter).  Binding curves were analyzed using Graphpad Prism Version 4.00 
(Graphpad Software, San Diego, CA) curve fitting software for non-linear 
regression.   
 
 
2.4 Results and Discussion 
2.4.1 Gold nanoparticles (GNPs) synthesis  
 GNPs of different size, shape, and surface chemistry were prepared 
accordingly to our standard procedure.2 Representative UV-Vis spectra, zeta 
potential measurements, and TEM image are shown for aspect ratio 3.5 GNRs 
(Figure 2.1 and 2.2). The dimensions of the different GNPs are ~54 × 16 nm 
(short GNRs), 342 × 21 nm (long GNRs), and 20 nm (spherical GNPs) compared 
to 14 × 4 × 4 nm for BSA molecules.   
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 Figure 2.1. (A) UV-vis absorbance of GNRs capped with a CTAB bilayer (-–), 
after being wrapped with the negatively charged polyelectrolyte PAA via 
electrostatic interaction (−−), with a second layer of the positively charged 
polyelectrolyte PAH (−); and after displacing the CTAB using a thiolated PEG to 
form PEG capped GNRs (). (B) Zeta potential measurements show changes in 
surface charge as gold nanoparticles are functionalized with different polymers.  
BA
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Figure 2.2. Transmission electron micrographs of: (A) gold short nanorods of 
aspect ratio 3.5; (B) gold nanospheres of diameter around 20 nm; (C) long gold 
nanorods of aspect ratio 18. 
 
 
 
 
 
 
A B
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2.4.2 Steady-state fluorescence measurement in the presence of gold 
nanoparticles 
 Understanding the adsorption process between BSA and GNPs requires 
the quantification of the binding strength between BSA and gold nanoparticle. We 
have prepared cationic, anionic, and neutral gold nanoparticles and incubated 
them with BSA. The capability of metallic nanoparticles to quench the 
fluorescence of molecules located less then 10 nm from their surface can be 
employed to quantify the adsorption parameters.21 This method allows the 
determination of binding constants without the need to separate free versus 
bound protein and has been used in previous works.16,33 Through a titration 
process, we measured the decrease in fluorescence intensity of a constant 
amount of BSA as the concentration of gold nanoparticles was increased until 
saturation and thus, no further decrease in fluorescence was observed. If we 
assume static quenching, the fluorescence lifetime of the receptor is not altered 
since GNP-protein complexes do not fluoresce.  Therefore, we can modify the 
Stern-Volmer relationship, an established model for this method, as follows:16,34  
 
F0/F = 1 + Ka [GNPs]               (equation 2.1) 
Kd = [F0-F] / [F-F∞][GNPs] n      (equation 2.2) 
Ka = 1/Kd                                                  (equation 2.3) 
                                                      
where F0 is the total fluorescence of BSA (in the absence of GNPs), F is the 
fluorescence of BSA at a specific nanoparticle concentration, F∞ refers to the 
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fluorescence of BSA at GNPs saturation. Kd and Ka refers to the dissociation and 
association constants respectively, and n is the Hill coefficient,35 which describes 
the degree of cooperativity. If n > 1, the binding of a ligand is enhanced if there 
are already other ligands adsorbed to the surface. If n < 1, the binding of a ligand 
is decreased if there are already other ligands adsorbed to the surface. In cases 
where n=1, the binding of a ligand is independent of other ligands already at the 
surface. To calculate binding constants and Hill coefficients, a double logarithmic 
plot was used based on the Hill equation: log [(F0-F)/(F-F∞)] versus log [GNPs]. 
Figure 2.3 shows the fluorescence spectra of BSA incubated with increasing 
concentration of GNRs of aspect ratio 3.5 and different surface chemistries. The 
presence of GNPs causes the fluorescence of BSA to decrease. The 
concentration of the GNPs in the solution was increased up to saturation point. 
Assuming the Stern-Volmer constant to be equal to Ka for a static quenching 
model, Figure 2.4 shows the binding curves obtained for GNRs using the Hill 
equation. From those binding curves, we calculated binding constants (Ka) of 
(1.48 ± 0.25) × 1010 M-1, (0.95 ± 0.09) × 1010 M-1, and (0.51 ± 0.02) × 1010 M-1 for 
PAH-GNRs, PAA-GNRs, and PEG-GNRs respectively. Hill coefficients 
(cooperativity of binding) were also derived (n): 1.18 ± 0.12, 1.28 ± 0.04, and 
1.34 ± 0.20 for PAH-GNRs, PAA-GNRs, and PEG-GNRs. The experiment was 
repeated for longer GNR of aspect ratio ~18 and gold nanospheres of diameter 
around 20 nm. Table 2.1 summarizes the calculated binding constants and Hill 
coefficients for the different type of nanoparticles.  
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Table 2.1. Calculated binding (Ka) and Hill constants (n) for GNPs with different 
surface charge with BSA. Solvent: pure water.  
 
 
PAA coated (-) PAH coated (+) PEG coated  
(neutral) 
sp
he
re
 
20
 n
m
 Ka(×  10
10 M-1) 0.30 ±  0.04 1.71 ±  0.33 0.28 ±  0.01 
n 0.93 ± 0.31 0.57 ± 0.04 1.36 ± 0.09 
ro
d 
A
.R
. 3
.5
 Ka (×  1010 M-1) 0.95 ±  0.09 1.48 ±  0.25 0.51  ±  0.02 
n 1.28 ± 0.04 1.18 ± 0.12 1.34 ± 0.20 
ro
d 
A
.R
. 1
8 Ka (×  10
10 M-1) 1.22  ±  0.08 2.75  ±  0.49 0.82  ±  0.54 
n 1.11  ± 0.03 0.72  ± 0.15 1.16  ± 0.36 
 
 
 From these values, three main trends were observed: 
1- PEG-GNPs do not resist protein adsorption at their surface since the 
calculated binding affinities for different GNPs with PEG molecules at their 
surface were similar to other surface chemistries.  
2- PAH-GNPs of any shape with a positive charge have higher affinities 
compare to other GNPs surface for BSA, which is negatively charged at 
pH around 7-8 (pI 4.7). Thus, electrostatic interactions play a significant 
role in the binding process between proteins and nanoparticle surface.  
3- Hill coefficients in most cases are higher than 1 hinting toward cooperative 
binding.  
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Figure 2.3. Fluorescence spectra of BSA at 0.66 µM with increasing 
concentration (0-3 nM) of differently charged GNRs (A.R. 3.5) showing the 
decrease in protein fluorescence with increasing concentration of GNRs: (A) 
PAA-GNRs; (B) PAH-GNRs; and (C) PEG-GNRs. 
 
 
 
 
 
A B 
C 
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Figure 2.4. Double logarithmic depicting the binding curve resulting from the 
adsorption of BSA to GNRs surface: (A) PAA-GNRs; (B) PAH-GNRs; and PEG-
GNRs.  
 
  
 
 
 
 
 
A B 
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2.4.3 Probing electrostatic interaction 
 To investigate the effect of electrostatic interactions on protein-
nanoparticle binding, the adsorption process was investigated by repeating the 
fluorescence quenching experiment in MOPS buffer (5 mM). Higher 
concentrations of buffer tended to aggregate the GNPs. The calculated Ka values 
in buffer are similar to values obtained in ultrapure water (same order of 
magnitude, Table 2.2). This supports the idea that other attractive forces besides 
electrostatic forces play an important role on the adsorption of protein to the 
surface of GNPs.36  
 
 
Table 2.2. Calculated binding constants (Ka) of BSA on short GNRs (aspect ratio 
3.5) in water versus buffer 
 
 Furthermore, to quantify the contribution of the electrostatic interaction we 
performed a salt titration experiment.  Sodium chloride was titrated into a gold 
nanoparticle-protein complex solution in order to shield the electrostatic 
interaction between PAH-GNPs (spheres) and BSA protein. As the ionic strength 
of the solution was increased we observed an enhanced fluorescence of the 
protein (Figure 2.5 A). This enhanced fluorescence is caused by the extra ions 
competing for the gold nanoparticles surface causing desorption of BSA and 
 PAA-GNRs PAH-GNRs PEG-GNRs 
Ka (M-1) in water (0.95 ± 0.09) × 1010 (1.48 ± 0.25) × 1010 (0.51 ± 0.02) × 1010 
Ka (M-1) in MOPS (0.97 ± 0.02) × 1010 (2.40 ± 0.19) × 1010 (1.39 ± 0.13) × 1010 
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therefore a decrease of the quenching effect. We used the Frisch-Sihma-Eirich 
adsorption isotherm (FES) to determine the electrostatic contribution to the 
binding of BSA to the surface of the GNPs since it yielded the best fit for the salt 
titration experiment and Kobs values at each salt concentration could be 
calculated by setting the parameters ν=1 and K1=0.5 (equation 2.4). This model 
assume the decrease in fluorescence is proportional to surface coverage of the 
GNPs.37 Using the polyelectrolyte theory38, the log of the Kobs values were plotted 
against the log of the salt concentrations to yield the slope SK. SK was used to 
calculate the electrostatic contribution to the free energy change upon binding 
(ΔGelec) at each salt concentration using equation 2.5. ΔGobs was calculated from 
the previous titration experiment performed for PAH-GNS, this time using the 
FES adsorption isotherm to calculate Kobs for more accurate comparison, again 
setting the parameters ν=1 and K1=0.5 in equation 4. We used equation 2.6 to 
derive ΔGobs. Figure 2.5 (B) represents the binding isotherm obtained for PAH-
GNS and BSA interaction using FES.  
 
[θ exp (2K1θ)]/(1-θ) = (KobsC) 1/ν     (equation 2.4) ΔGelec = SK (RT) ln [NaCl]                
(equation 2.5) 
ΔGobs = -RT ln Kobs                           (equation 2.6) 
 
In equation 2.4, θ represents the fractional change in luminescence and is equal 
to [(F-F0)/(Ffinal –F0)] where F is equal to the fluorescence at an arbitrary point. C 
is the concentration of GNPs. K is the equilibrium constant for binding. K1 and ν 
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are parameters pertaining to segment of polymer adsorbed since this model is 
based on adsorption of long polymers on flat surfaces. In our case, those values 
were set to obtain the best possible fit. In equation 2.5 and 2.6, R is the gas 
constant and T is the temperature. The following values were obtained: ΔGobs= -
56.9 ×103 J/mol and ΔGelec= -11.5 ×103 J/mol. This represents an electrostatic 
contribution of about 20% for the binding for BSA to the surface of PAH-GNPs. 
This result confirms our finding that electrostatic interaction is not the sole force 
responsible for the adsorption of proteins to nanoparticles surface. Other forces 
such as London dispersion and hydrogen-bonding can also lead to protein 
adsorption.36  
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Figure 2.5. (A) Fluorescence spectra of BSA fluorescence (0.5 µM) in the 
presence of PAH coated gold nanospheres (20 nm) with varied NaCl 
concentration (0-5 mM). As the NaCl concentration increased, so does the 
fluorescence of BSA confirming the importance of electrostatic interaction. (B) 
Frisch-Simha-Eirich plot for BSA adsorption to PAH coated gold nanospheres to 
obtain Kobs. The best fit was obtained for K1 = 0.5 and ν = 1.  
 
 
 
 
 
 
 
 
 
 
A B
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 Looking at the literature, it is clear that there is a significant discrepancy in 
the reported gold nanoparticles-protein binding constants, which fall anywhere 
from 104 to 1011 M-1. 23,33,39 Our results are within range when compared to other 
publications using the fluorescence quenching approach. However, other 
methods such as circular dichroism spectroscopy and quartz crystal 
microbalance have yielded lower values (Table 2.3). The higher Ka values 
obtained using steady-state fluorescence measurements might be caused by the 
GNPs optical interference. To confirm this effect, we used GNRs pre-incubated 
with excess BSA proteins as controls (set 1), in parallel, with bare GNRs (set 2) 
in the titration step, an approach used previously in our lab.25 In the case of 
GNRs pre-incubated with excess BSA (set 1), we would expect minimal 
quenching as we added a fixed amount of BSA to increasing GNRs 
concentrations, similarly to the previous titration. However, we observed the 
additional BSA to be “quenched” efficiently. Assuming the pre-incubated 
particle’s surface to be saturated with proteins we can only attribute this 
decrease in protein fluorescence to GNRs optically interfering with our 
measurements to a significant degree. From this observation, we derived 
correction factors (Θ) at each GNRs concentration in set 1 by dividing the 
fluorescence at each titration point F by F0 (free protein). The influence of the 
GNRs can then be factored and removed from the fluorescence titration data 
obtained in set 2 by dividing the fluorescence observed at each titration point (F) 
by the respective correction factor obtained from set 1 (Θ).  We found the binding 
constants to be reduced from 5.72 × 109 M-1 to 2.98 × 109 M-1 for GNRs of A.R. 
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3.5 when corrected. This represents a reduction of almost half of the original 
value. However, the results are not significant enough to account for the higher 
binding constants obtained using the fluorescence quenching technique. Clearly, 
an independent binding technique is required.  
 
Table 2.3. Published binding constants of GNPs on BSA as reported by different 
research groups  
 
 
 
2.4.4 Affinity Capillary Electrophoresis (ACE) to probe GNPs and BSA 
interaction 
 
 Classical ACE41 has been utilized to evaluate the interaction between 
GNPs and BSA as a comparative method to steady state fluorescence 
measurements. There are several advantages to measuring the dissociation 
Nanoparticle Shape Size Solvent Method  Ka (M-1) Author 
Citrate-GNP sphere 18 nm water Fluorescence 2.34 × 1011 Losin et al. (2009)33 
CTAB-GNP rod 70×30 
nm 
water Fluorescence 5.0 × 104 Losin et al. (2009)33 
Glut-GNP sphere 40 nm PBS Fluorescence 3.16 × 1011 Wangoo et al. 
(2008)39 
Citrate-GNP sphere 20 nm water CD 7.14 × 108 Truel et al. (2010)40 
Citrate-GNP sphere 10 nm  water QCM 1.0 × 106 Brewer et al. 
(2005)22 
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constant of the GNP-BSA complex by capillary electrophoresis. Importantly, the 
separations are rapid and consume low volumes of reagent and sample.  In this 
work, capillary electrophoresis runs were completed in 7 minutes using 20 µL 
volumes of nanoparticle solution. In the absence of protein in the background 
electrolyte, the migration velocity of gold nanorods, defined as v= µaE, is a 
function of the apparent mobility, µa and the applied electric field, E. The 
apparent mobility is the sum of the bulk electroosmotic flow, µeof, which occurs as 
a consequence of the charged capillary surface and applied field, and of the 
analyte electrophoretic mobility, µeph, related to the ratio of the charge and 
hydrodynamic radius.42 If the charge-to-size ratio of the protein-nanoparticle 
complex is different from that of the free nanoparticle, then the migration velocity 
of complex differs from the unbound nanoparticle.  The migration time reflects the 
amount of time the nanoparticle is bound to protein.   
The GNPs-BSA dissociation constant was determined by changing the amount of 
protein ligand present during the separation and by measuring the fraction of the 
nanoparticle that exists as a complex.  This fraction, f1, which describes the ratio 
of the bound nanoparticle to total nanoparticle, is fit to a hyperbolic binding 
isotherm using nonlinear regression.  The ratio f1 was derived from the change in 
migration time associated with change in the concentration of the protein ligand 
in the background electrolyte. The equation used for rapidly equilibrating receptor 
and ligand has been previously reported.41,43 
 µapp = f1µmax + f2µfree     (equation 2.7) 
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Where μapp is the apparent mobility of the nanoparticle measured using a 
specific concentration of ligand in the background electrolyte, µmax is the mobility 
of the nanoparticle-protein complex, µfree is the mobility of free nanoparticles and 
f2 the fraction that is free.  The above equation is simplified by substituting the 
variable f2 with (1- f1) and then rearranged as f1 = (µapp - µfree)/(µmax - µfree).  
Dissociation constant, KD, which relates the forward and reverse rate constants 
for the binding of acceptor (i.e. nanoparticle) and protein ligand, is derived using 
the Hill equation.  
f1 = [protein]n / (KDn + [protein]n)   (equation 2.8) 
Again here, the Hill coefficient (n), describes binding cooperativity.  Equations 2.7 
and 2.8, model the homogeneous binding interaction between ligand and 
acceptor in cases where complex formation occurs without an intermediate state 
or with a short-lived intermediate.35,43  
 The parameters described by equations 2.7 and 2.8 were determined 
experimentally with ACE to derive the binding parameters for both PAA-GNRs 
and PEG-GNRs using a bare fused silica capillary. Upon addition of BSA to the 
background electrolyte, the electroosmotic flow decreased due to the formation 
of BSA-GNR complexes. Therefore, the capillary surface was renewed in 
between each separation and the electroosmotic flow was measured for each 
separation run using a neutral marker, dimethylformamide, detected at 214 nm.  
The electrophoretic mobility of protein nanorod complex was determined by 
subtracting the electroosmotic flow from the apparent mobility. Results are 
summarized in Table 2.4. A shift in the mobility of the PAA-GNRs (7.4 nM), 
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detected at 300 nm, was measured using background electrolyte (5 mM MOPS) 
containing BSA ranging from 0 to 50 µM (Figure 2.6). For PEG-GNRs (6.2 nM),  
a shift in the mobility was measured at 325 nm, with increasing concentrations of 
BSA in 5 mM MOPS buffer (Figure 2.7)  The data were fit to equation 2.8  
yielding binding constants (Ka) of (7.91 ± 0.49) × 104 M-1 and (1.53 ± 0.09) × 104 
M-1 for PAA-GNRs and PEG-GNRs, respectively (Figures 2.8-2.9). Hill 
coefficients were found to be 2.28 ± 0.31 and 2.19 ± 0.27 for PAA-GNRs and 
PEG-GNRs, respectively. This technique also confirms the adsorption of protein 
to the surface of pegylated GNPs with the same level of affinity as for other 
surface types. We were not able to calculate a binding constant for PAH-GNRs, 
possibly due to the strong interaction of the positively charged particles with the 
inner wall of the capillary. Furthermore, the strong interaction of PAH-GNRs with 
the BSA protein caused a rapid aggregation of the nanomaterials in the presence 
of BSA.  
 
Table 2.4. Calculated binding parameters using ACE in 5 mM MOPS 
Binding Parameters PAA-GNRs PEG-GNRs 
Ka (M-1) (7.91 ± 0.49) × 104 (1.53 ± 0.09) × 104 
n 2.28 ± 0.31 2.19 ± 0.27 
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Figure 2.6. Electropherogram of PAA-GNRs (7.4 nM) detected at 300 nm with 
increasing concentrations of BSA, as listed, in 5 mM MOPS buffer. As the 
concentration of the of BSA increases in the running buffer, a shift in the 
apparent mobility of the GNRs is observed. Concentrations of BSA from bottom 
to top are: 0, 5, 10, 15, 25, 35, and 50 µM.  
0"μM"
5"μM"
10"μM"
15"μM"
25"μM"
35"μM"
50"μM"
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Figure 2.7. Electropherogram of PEG-GNRs (6.2 nM) detected at 325 nm with 
increasing concentrations of BSA in 5 mM MOPS buffer. The wavelength 325 nm 
was selected to minimize interference from a negative peak that occurs around 
4.2 minutes from the absence of BSA in the running buffer.  As the concentration 
of the of BSA increases in the running buffer a shift in the apparent mobility of the 
GNRs was observed. Concentration of BSA from bottom to top are: 0 µM, 25 µM, 
35 µM, 50 µM, 75 µM, 100 µM, 150 µM and 200 µM.  
 
 
 
 
 
 
0"μM"
25"μM"
35"μM"
50"μM"
75"μM"
100"μM"
150"μM"
200"μM"
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Figure 2.8. Model fitting curve of PAA-GNRs (7.4 nM) detected at 300 nm with 
increasing concentrations of BSA in 5 mM MOPS buffer. Sets 1-3 are replicates 
and the pooled curve is the average of the 3 sets.  
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Figure 2.9. Model fitting curve of PEG-GNRs (6.2 nM) detected at 325 nm with 
increasing concentrations of BSA in 5 mM MOPS buffer. 
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 The binding constants obtained using ACE do fall in the low end of the 
range in Table 2.3 and provide insight about cooperativity. Similarly to the 
fluorescence measurements, the calculated Hill coefficients are higher than 1, 
confirming a cooperative binding. However, ACE yielded 105x lower binding 
affinities compare to steady state fluorescence measurements in this work. The 
values calculated are within the range of what as been reported using other 
techniques. Lacerda et al. reported binding range between 104-107 M-1 for plasma 
proteins adsorbing to gold nanospheres.44 The advantage of looking at the shift 
in mobility in affinity mode is that one can differentiate between BSA-GNRs 
complex and free GNRs without the need of harsh separation steps. More 
importantly, we also do not rely on the optical properties of the GNPs to obtain 
quantitative information on the binding process, which can lead to optical 
interference. Thus, by using this method we are able to eliminate certain factors 
that can contribute to inaccurate thermodynamic measurements.  
 
2.4.5 Kinetic study of the adsorption of BSA to the surface of GNRs 
 To investigate the rate of adsorption of BSA on different gold nanorod 
surfaces and thus, how electrostatic interactions affect the kinetic process. We 
have taken advantage of the sensitivity of the longitudinal plasmon resonance 
(LSPR) of the gold nanorod. A photodiode array spectrophotometer was used to 
monitor the adsorption of BSA to the surface of GNRs (A.R. 3.5) by monitoring 
wavelength shifts in the LSPR band maximum over a time scale of 0-1000 
seconds (Figure 2.10). The LSPR is highly sensitive to change in local refractive 
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index at the surface of the GNRs. We observed a slow adsorption process of 
BSA to PAA-GNRs and PEG-GNRs. However, the adsorption process is a faster 
to the surface of PAH-GNRs (less than 10 seconds). At equilibrium, only PAH-
GNRs show a significant red shift (Δ~20 nm) of their LSPR and significant peak 
broadening. PAA-GNRs only show a slight red shift (Δ~5 nm), whereas PEG-
GNRs show no significant shift even at equilibrium. This suggests that the charge 
of the particles might dictate the rate of the adsorption process. Using a modified 
pseudo-second order kinetic model (equation 2.9),45,46 which assume that the 
BSA concentration is present in excess, meaning that its concentration in the 
bulk solution do not vary much upon adsorption of the protein to GNR surface, 
the adsorption kinetic curve of the PAH-GNRs was successfully fitted.  
t/Δλ = t/Δλe + 1/k2 (Δλe)2                     (equation 2.9) 
where k2 is the second order rate constant, t is time, and Δλ and Δλe are the 
shifts in LSPR wavelength at time t and after equilibrium is reached respectively. 
Using this model we found k2 to be equal to about 10-3 s-1 nm-1 for BSA 
adsorbing to PAH-GNRs. Little changes in adsorption kinetics for both PAA-
GNRs and PEG-GNRs complicated the fitting process, thus rate of adsorption for 
both PAA-GNRs and PEG-GNRs are not reported.  
 
 
   
 
 
	   56	  
 
 
 
Figure 2.10. Longitudinal plasmonic absorbance peak shift of GNRs over a short 
time scale (0-1000 seconds) as BSA is introduced to GNR solutions (A.R. 3.5). 
(A) PAA-GNRs show a small red shift of about 5 nm after ~100 seconds; (B) 
PAH-GNRs show a red shift of about 20 nm immediately after BSA addition; and 
(C) PEG-GNRs show no significant shift. Figure 6 (B) show a linear pseudo-
second-order kinetic curve for BSA adsorbing to PAH-GNRs.  
 
 
 
 
 
 
 
 
 
BA
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2.5. Conclusion  
 In this work, two different techniques were used to derive binding 
constants and Hill coefficients on the binding process of BSA to the surface of 
gold nanoparticles varied as a function of size, shape, and surface charge. We 
found BSA to adsorb to the surface of PEGylated GNPs with similar affinity as for 
other types of GNPs using both methods. Thus, “protein-resistant” PEG cannot 
withstand BSA, which is known to “stick to everything”. Our results agree well 
with other published reports for the same analytical method. However there is a 
wide variation in binding affinity range reported from method to method to probe 
nanoparticle-protein complexes. Therefore, this field desperately needs the 
development of techniques that can accurately probe the binding parameters 
during the adsorption process of proteins. We have found affinity capillary 
electrophoresis to be a suitable method to investigate the binding process. The 
calculated binding affinities obtained with this method were in the same range as 
previous reports. We believe this technique is currently one of the most reliable 
methods to investigate the adsorption of protein to the surface of gold 
nanoparticles since the mobility of the GNRs is probed directly using absorbance 
measurements, without pre-separation steps, and it does not suffer from GNR 
optical interference. Further experimentation with this technique will allow the 
development of better methods with the goal of calculating binding parameters 
for a wide range of proteins.  
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CHAPTER 3 
 
INVESTIGATION OF PROTEIN-GOLD NANOPARTICLE INTERACTIONS 
USING DIFFERENT SPECTROSCOPIC TECHNIQUES 
 
 
3.1 Notes and Acknowledgments  
 The author would like to acknowledge Changqian Yu and Prof. Steve 
Granick for their assistance with both one-photon and two-photon FCS 
measurements.  
 
3.2 Introduction 
As mentioned in Chapter 2, gold nanoparticles (GNPs) have been the 
subject of much scientific attention due to their strong and tunable optical 
properties.1 A variety of applications are being investigated for biomedical 
purposes.1-5 However, GNPs can impair the function of living cells and organisms 
as biomolecules interact with their surface.6-11 Therefore, before they can be 
employed safely in humans, a better understanding of the protein corona that 
forms around the GNPs once in the biological environment is imperative. The 
nature of the protein corona is an important parameter that will dictate GNPs 
cellular interaction and ultimately biological functions.12 Furthermore, the size, 
shape, and surface chemistry of the GNPs can lead to variations in protein-GNP 
interactions. Therefore, there is a need for scientists to develop analytical 
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methods that can accurately probe the interaction between proteins and GNPs in 
order to create a library of information that will help in controlling the fate of the 
nanomaterial in the biological system.  
 So far, a variety of techniques have been used to gather thermodynamic, 
kinetic, and structural information on the interaction of proteins with nanoparticles 
in an attempt to predict how cellular systems will respond to the presence of 
nanoparticles. For GNPs, different analytical techniques have been used to 
investigate protein-GNPs interactions. The intense optical properties of gold 
nanomaterials facilitate the use of spectroscopic methods. A variety of optical 
techniques such as UV-Vis spectrophotometry,13,14 fluorescence,15-18 circular 
dichroism13,19,20 and dynamic light scattering18,21,22 have been employed to probe 
the interaction of protein to nanomaterials. However, most of these methods can 
suffer from lack of sensitivity and reports from lab to lab can vary widely, as it has 
been observe for affinity measurements (see Chapter 2). This highlights the need 
for a more robust and versatile method to probe the interactions of nanomaterials 
with biomolecules.  
 Fluorescence correlation spectroscopy (FCS) is a versatile and highly 
sensitive technique to characterize the chemical, physical, and dynamic 
properties of biomolecules and biological systems.23 In recent times, FCS has 
been employed as a technique to probe protein-nanoparticle interactions.24,25 It is 
a unique technique in that it can measure the diffusion of small particles through 
statistical analysis of burst of photons emitted by either the protein or the 
nanomaterial as the diffused through a small observation volume (femtoliter) 
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without the need to separate free versus bound protein.25 Using correlation 
analysis, it allows the measurement of parameters such local concentrations, 
translational or rotational diffusion coefficients, and association and dissociation 
constants for the interactions of nanomaterials with biomolecules in vitro as well 
as in vivo.26 Furthermore, its applications can be extended with the addition of 
new technical features such as two-photon excitation and total internal 
reflection.26  
 In this chapter, we investigate the use of different spectroscopic 
techniques and highlight their advantages and disadvantages in measuring GNP-
protein interactions. Both UV-visible and fluorescence spectroscopy have been 
investigated as possible methods to determine amounts of bovine serum albumin 
(BSA) binding to GNRs surface. These techniques involves the separation of free 
versus bound BSA after incubation using centrifugal forces in order to quantify 
the amount of bound BSA. Separating free from bound protein using harsh 
methods such as centrifugation can lead to inaccurate and irreproducible 
measurements. This gave us the incentive to probe FCS as a direct 
measurement technique. Both one and two-photon FCS are presented as 
techniques to probe BSA-GNRs interactions. In one-photon FCS, we rely on the 
fluorescence of fluorophore-labeled BSA. To prevent the quenching effect of the 
GNR, silica was used as a spacer at the surface of the GNR.  
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3.3 Experimental Section 
 
3.3.1 Materials. Chloroauric acid (HAuCl4 .3H2O, 99.9%), sodium borohydride 
(NaBH4, 99%), silver nitrate (AgNO3, 99+%), cetyltrimethylammonium bromide 
(CTAB, 99%, Sigma Ultra), ascorbic acid (99+%), poly(acrylic acid, sodium salt), 
~15,000 g/mol, 35% wt in water, and poly(allylamine hydrochloride), ~15,000 
g/mol, tetraethyl orthosilicate (TEOS), (3-aminopropyl)trimethoxysilane (APTMS),   
were obtained from Sigma-Aldrich and used as received. Thiolated poly(ethylene 
glycol), 5,000 g/mol, was purchased from Nanocs. N-
(trimethoxysilylpropyl)ethylenediaminetriacetate, trisodium salt (35% in water) 
and 2-[methoxy(polyethyleneoxy)propyl]trimethoxysilane were purchased from 
Gelest. Bovine serum albumin (BSA) was purchased from Sigma Life Sciences. 
BSA with a fluorescein conjugate and BSA with an Alexa fluorophore 488 
conjugate were purchased from Invitrogen. Phosphate buffer saline (PBS) used 
was from Lonza. 3-(N-morpholino)propanesulfonic acid (MOPS) was purchased 
from Alfa Aesar.  All GNP solutions were prepared with purified 18 M.Ω water. 
Glassware was cleaned with aqua regia and rinsed thoroughly with deionized 
water.  
 
3.3.2 Instrumentation. Absorption spectra were taken on a Cary 500 scan UV-
vis-NIR spectrophotometer. Transmission electron microscopy (TEM) data were 
obtained with a Joel 2100 Cryo electron microscope operating at 200 kV. TEM 
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grids were prepared by drop casting 10 µL of purified gold nanoparticle solution 
on the TEM grids and drying them in air. Zeta potential measurements were 
performed on a Brookhaven Zeta PALS instrument. Steady-state fluorescence 
measurements were performed on a Jobin Yvon Horiba Fluoromax-3 
spectrophotometer. Fluorescence measurements using 96-well plates were 
taken using a Spectramax M2 multi-detection reader. Both one and two-photon 
FCS measurements were made in Prof. Steve Granick’s laboratory (FCS 
sections for further instrument description).  
 
3.3.3 Gold Nanoparticles synthesis. Gold nanorods were prepared using 
simple wet chemical method in the presence of the surface capping agent 
cetyltrimethylammonium bromide as previously described.2,27-29 A solution of 2.5 
× 10-4 M HAuCl4 was prepared in 0.1 M aqueous CTAB in a 50 mL centrifuge 
tube. NaBH4 (600 µL, of a 10 mM stock solution) was added to the gold/CTAB 
solution (10 mL) with vigorous stirring for 10 min with the help of a stir bar. The 
resulting seed particles (~3 nm diameter) were used for the synthesis of both 
short and long gold nanorods. For gold nanorods (aspect ratio 3.5) the following 
were added, in order, to a conical flask: CTAB solution (95 mL of a 0.1 M stock 
solution), silver nitrate solution (1 mL of a 10 mM stock solution), and HAuCl4  (5 
mL of a 10 mM stock solution). An aqueous solution of ascorbic acid (0.55 mL of 
a 0.1 M stock solution) was then added with gentle mixing. Finally, the gold seed 
solution (0.12 mL) was added and mixed. The solution was left undisturbed 
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overnight. The colored gold nanorod solution was purified by centrifugation (2X) 
to remove excess CTAB.  
 
3.3.4 Polyelectrolyte Coating of Gold Nanoparticles. GNPs coated with 
different layers of polyelectrolytes were prepared by the layer-by-layer adsorption 
technique.30 Sodium polyacrylic acid (PAA) and poly (allylamine hydrochloride) 
(PAH), each with a molecular weight of approximately 15,000 g/mol, were used. 
200 µL of polyelectrolyte solution (10 mg/mL prepared in 10 mM NaCl solution) 
and 100 µL NaCl solution (10 mM) were added simultaneously to every 1 mL 
purified CTAB capped GNPs solution of different shape and size. The resulting 
solution was mixed gently and incubated overnight to allow for complete polymer 
coating.  To remove of the excess polyelectrolyte in solution, GNPs were 
centrifuged at 7000 rpm for 30 minutes and redispersed in water. GNPs were 
further dialyzed for 24 hours to ensure removal of excess reagents using 20K 
MWCO dialysis cassettes. 
 
3.3.5 Synthesis of SiO2-GNRs and Silane Functionalization. To coat the 
GNRs surface with silica, CTAB was added to a solution of purified gold 
nanorods to give a final CTAB concentration of 0.8 mM. Then 20 µL of 0.1 M 
NaOH was added to the solution while stirring. After 30 minutes, 30 µL of 20% 
TEOS (in methanol) was added. Again, after another 30 minutes, 30 µL of 20% 
TEOS (in methanol) was added. The solution was left to react overnight and 
purified by centrifugation (5000 rpm, 20 minutes) the next day. After 
	   71	  
centrifugation, SiO2-GNRs were resuspended either in water or ethanol. For the 
silane functionalization, 10 µL of APTMS or PEG silane were added to every 2 
mL of SiO2-GNRs in ethanol. For the triacetic silane only 5 µL was added to 
every 2 mL of SiO2-GNRs in ethanol. The solutions were shaken for 2 hours and 
then placed in a water bath at 50° C for 1 hour. Silane functionalized SiO2-GNRs 
were then purified by centrifugation at 5000 rpm for 20 minutes.  
 
 
 
3.3.6 Fluorescence measurements of GNR-BSA interaction. PAA, PAH, and 
PEG coated GNRs at final concentration of (0.27 nM) were incubated with 
increasing concentrations of fluorescein tagged BSA (0.025-2.5 µM) in PBS 
buffer. All solutions were prepared in triplicates at a final volume of 0.5 mL. 
Samples were incubated overnight. Two centrifugation steps at 10,000 rpm for 
15 minutes were performed to separate supernatant and pellet. 200 µL of the 
supernatant of each solution was placed in a microplate reader and emission 
was measured at 520 nm with an excitation wavelength of 496 nm. The 
measured fluorescence intensities were converted to molar BSA concentration 
using a pre-made calibration curve.  
 
3.3.7 Single photon FCS measurements of GNR-BSA interaction. A one-
photon excitation FCS set-up was built based on a Zeiss Axiovert 200 inverted 
microscope.  One-photon excitation was achieved by using a Coherent 488 nm 
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optical pumped semiconductor laser.  In this setup, the laser beam is split into 
two, namely, the bleach beam and the probe beam.  In the case of FCS, only the 
probe beam is introduced into the microscope through a beam expander. The 
expanded beam is then reflected by a 488 nm dichroic mirror and is tightly 
focusing at the sample by an objective lens (LD Plan-Neofluar Zeiss, 63X, 
numerical aperture (N.A.) = 0.75, working distance = 2.2 mm).  The combination 
of a dichroic mirror, a notch filter (Kaiser Optics Systems, Inc) and a long pass 
filter is used to remove the background scattering light.  The emitted 
fluorescence is collected through the same objective, refocused by the tube lens, 
and redirected to the bottom port of the microscope with a switchable mirror.  A 
30 µm pinhole is used at the focal point underneath the bottom port to establish 
the confocal geometry.  The emitted fluorescence signal is collinearized after the 
pinhole and then focused to an Avalanched Photon Detector (APD) based 
photon counting module (SPCM-AQR-14, Perkin Elmer Optoelectronics) by a 
pair of achromatic lenses.  The digitalized output is collected by a NI-PCI6602 
data acquisition board (National Instrument Inc.) and correlated by a Labview 
based software. By introducing the laser through the objective lens, a small 
excitation volume (~ 1 fL) is generated within the sample.  The dimensions of the 
excitation volume generated by the probe beam were about 0.35 mm in width 
and 15 µm in height, as determined by measuring the diffusion of fluorescent dye 
molecules, Rhodamine 110 standard (Molecular Probes Inc.), whose diffusion 
coefficient in water is known to be about 280 mm2/s. Diffusion coefficient of BSA 
tagged with Alexa 488 fluorophore was measured both free in solution and in the 
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presence of SiO2-GNRs. BSA-Alexa was measured at a concentration of 1 nM 
and SiO2-GNRs at about 0.01 nM. Protein and nanomaterial were mixed and 
incubated overnight.  
 
3.3.8 Two-photon FCS measurements of GNR-BSA interaction. A two-photon 
FCS system was built based on a Zeiss Axiovert 135 microscope. Near-infrared 
light from a femtosecond Ti:sapphire laser (800 nm, 80 MHz, pulse width ~100 
fsec) was focused, through a long working distance objective (63X, NA = 0.75), 
into the contact between opposed mica sheets. Fluorescence was excited only at 
the focus of the laser spot, the laser power at the sample being ≈ 1 mW. It was 
collected through the same objective and detected by a single photon counting 
module (Hamamatsu).  
 
 
 
3.4 Results and Discussion 
 
3.4.1 Spectroscopic study of BSA-GNR interaction via centrifugal 
separation 
  The capability of UV-visible absorbance and fluorescence spectroscopy 
to quantify the amount of protein bound to the surface of the gold nanoparticle 
was explored. The basis of this experiment involves separating free from bound 
BSA using centrifugal force. However, BSA is a large globular protein, 66 kDa, 
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with a size of around 14×4×4 nm.31 If we picture a gold nanoparticle that is 50 nm 
long and 10 nm wide, that translates to enough space for around 10 BSA 
molecules at the nanoparticle surface assuming monolayer adsorption.  We 
calculated the limit of quantification of BSA by UV-vis absorbance to be 0.6 µM 
using the equation YLOQ = Yblank + 10 Sblank.32 Where YLOQ represents the 
minimum signal necessary to be able to accurately quantify an analyte. Yblank is 
the average measured signal of the blank and Sblank is the standard deviation 
from triplicate measurements of the blank at 280 nm.  The synthesis of gold 
nanoparticles usually yields concentration of around 1 nM. Therefore, our 
sensitivity using UV-vis absorbance spectrophotometry is limited to about 600 
molecules of BSA per nanoparticles. The UV-vis absorbance technique therefore 
lacks the sensitivity for monolayer quantification of the adsorption process.  
 Fluorescence is a more sensitive method compare to absorbance 
spectroscopy. We calculated the limit of quantification of BSA to be 0.02 µM, 
which translate to 20 molecules per nanoparticle for a 1 nM nanoparticle solution. 
Fluorescence spectroscopy is therefore more suitable to monitor the binding 
process. To further, improve the sensitivity of the fluorescence measurements we 
used fluorescein isothiocyanate labeled BSA (BSA-F) which improves the 
quantum yield from 0.13 (tryptophan)33 to 0.65 (fluorescein)34 in water. We 
incubated PAA-, PAH-, and PEG-GNRs with increasing concentration of BSA-F 
overnight. Prior to fluorescent measurements, free BSA-tagged fluorescein was 
separated from BSA-GNR complex using centrifugation. The amount of free 
protein was quantified by measuring the fluorescence of the supernatant. 
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Samples were excited at 494 nm and emission was measured at 520 nm. The 
concentration of BSA adsorb to the GNRs surface was determined by subtracting 
the concentration of BSA in controls: Cbound= Ccontrol-Cfree. Figure 1(A) shows the 
plot of bound BSA versus free BSA, which gives an isotherm. The isotherm 
shows an increase in bound BSA concentration in the bulk along with increasing 
free BSA. The increase reaches a plateau indicating a saturation of the GNRs 
surface. We calculated the binding constant of BSA-F to the surface of the GNRs 
using the Langmuir adsorption isotherm35 instead of the Hill or FES models, 
since this isotherms has been shown to work well for comparing free versus 
bound ligand at the surface of GNR36 and the best-fit line as a R2 value of 0.99 
(equation 3.1): 
 
1/ Cbound = 1/(CmaxKCfree)+ 1/Cmax   (equation 3.1) 
 
where Cbound is the molar concentration of bound BSA-F to GNRs, obtained by 
difference from free and controls; Cfree is the molar concentration of leftover free 
BSA; Cmax is the maximum concentration of BSA that can adsorb to GNRs 
surface; and K is the equilibrium binding constant for the BSA-GNR complex. 
Figure 1(B) shows the double reciprocal plot of the isotherm data using equation 
1. A linear fit of the data resulted in a least-squares correlation coefficient of 0.99. 
From the linear fit we calculated Cmax to be equal to (1.84 ± 0.2) × 10-6 M and K 
to (3.32 ± 1.2) × 106 M-1 BSA-F absorbing to PAH-GNRs in phosphate buffer 
saline. This value falls in between binding affinities calculated using steady-state 
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fluorescence (~1010 M-1) and ACE (~104 M-1) in Chapter 2. It remained 
inconclusive whether PAA-GNR or PEG-GNR would have yielded lower binding 
similar to what we have observed for ACE. Since, we were not able to obtain 
proper isotherms for PAA- and PEG-GNRs. We believe the most important issue 
with this technique is the need to use centrifugal force to separate the free versus 
bound proteins. Centrifugation is a harsh method that can lead to protein 
desorption, agglomeration, and change in conformation.37 Furthermore, we have 
also experienced issues with certain types of GNRs sticking to polypropylene 
centrifuge tubes during centrifugation based on their surface chemistry. For these 
reasons, even though this technique does lead to accurate thermodynamic 
information in certain instances, it does not represent a robust technique that can 
be employed for the investigation for a wide range of nanomaterials and proteins. 
Thus, there is a need for the development of a more robust analytical method.  
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Figure 3.1. (A) Adsorption isotherm of fluorescein tagged BSA to PAH-GNR of 
aspect ratio 3.5. PAH-GNR concentration is 1 nM. Cfree is the concentration of 
BSA free in solution after 12 hours of incubation and subsequent purification. 
Cbound is the concentration of bound BSA to GNRs. (B) Double reciprocal plot of 
the isotherm data, the best-fit line has a R2=0.99.  
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3.4.2 Study of BSA-GNP interaction using single photon (FCS) 
 Fluorescence correlation spectroscopy (FCS) is a spectroscopic technique 
that allows for high-resolution spatial and temporal analysis of biomolecules or 
nanomaterials at low concentration. It takes advantage of the minute 
spontaneous fluctuations of physical parameters that are reflected by the 
fluorescence of the sample being measured. These fluctuations are then 
quantified in their strength and duration by temporally autocorrelating the 
recorded intensity signal using mathematical analysis. This allow the extraction of 
essential information regarding processes governing molecular dynamics.38 A 
general FCS setup is pictured in Figure 3.2. 
 A one-photon FCS was employed to analyze burst of photons from BSA 
labeled with the dye Alexa 488 both free and in the presence of GNRs in 
aqueous solution. GNRs are known to quench the fluorescence of molecules in 
close proximity with their surface. To avoid this, one option is to add a spacer to 
the surface of the GNRs. A 15 nm thick silica layer was grown to the surface 
using well-controlled chemistry and use as spacer.39 Figure 3.3 shows a 
transmission electron micrograph of aspect ratio 3.5 GNRs coated with silica.  
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Figure 3.2. Schematic drawing of the FCS setup.  A dichroic mirror directs the 
exciting radiation from a laser beam into a microscope objective focusing it on 
the sample. Fluorescence light from the sample is collected by the same 
objective, passes through the dichroic mirror and the emission filter, and is 
focused onto an avalanche photodiode detector (APD).  
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Figure 3.3. Transmission electron micrograph (TEM) of aspect ratio 3.5 GNRs 
with a silica layer of about ~15 nm at their surface. Scale bar = 200 nm.  
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 The SiO2-GNRs were incubated with BSA labeled with an Alexa 488 
fluorophore. The Alexa 488 dye was employed because of its enhanced 
photostability, which is high enough to withstand the enormous power at the focal 
point of the laser. At equilibrium, their diffusion coefficient was calculated by 
analyzing the fluorescence fluctuations caused by the fluorophore diffusing in 
and out of the excitation area over a specific period of time. Then, the 
experimental auto-correlation function was fitted with a two-dimensional 
Brownian diffusion model.  The auto-correlation function based on the theoretical 
model of two-dimensional Brownian motion for one photon excitation by 
assuming the 2-D Gaussian excitation profile can be written as:38,40 
 
 (equation 3.2) 
 
where D is the diffusion coefficient, <N> is the average number of molecules 
inside the laser spot,  is the diffusion time, and w0 is the diameter of the laser 
spot.41 From the resulting diffusion coefficients, hydrodynamic radii (hence 
diameter) were calculated according to the Stoke-Einstein relation: 
 
RH = kT/6πηD                                            (equation 3.3) 
 
where k is the Boltzmann’s constant, T is the absolute temperature, η is the 
viscosity, and D is the diffusion coefficient.  We found free BSA-Alexa to have a 
D = ~ 40 µm2/s, this corresponds to a diameter of 10.5 nm. In the case of BSA-
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Alexa incubated with SiO2-GNRs, D = ~3.1 µm2/s which yielded a diameter of 
146 nm confirming the association of BSA with the SiO2-GNRs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
	   83	  
 
Figure 3.4. Autocorrelation curves from luminescence of free BSA-Alexa (¢) and 
BSA-Alexa with SiO2-GNRs (n) in water. BSA-Alexa concentration was 1 nM and 
SiO2-GNRs was 0.01 nM.  
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Figure 3.5.  Fitted autocorrelation curves of the free BSA-Alexa (A) and BSA-
Alexa with SiO2-GNRs (B), which yield diffusion coefficients.  
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 Furthermore, in order to study the effect of particle charge on BSA 
adsorption, we have shown that it is possible to functionalize the surface of the 
silica coated GNRs with different silane molecules in order to vary the overall 
surface charge. Three types of silane molecule were chosen to attach to the 
silica coated GNRs.  2-[Methoxy(polyethyleneoxy)propyl] trimethoxysilane (PEG), 
(3-Aminopropyl) trimethoxysilane (APTMS), and N-(Trimethoxysilylpropyl) 
ethylenediaminetriacetate (Triacetic) were used to make neutral, cationic, and 
anionic GNRs respectively (Figure 3.6). By studying BSA interaction with 
different surface chemistry, we can create a library of information to better 
understand BSA-GNR interactions. Figure 3.7 shows both UV-visible absorbance 
and zeta potential data confirming the successful functionalization of the SiO2-
GNRs. However, all these necessary functionalization at the surface of the GNRs 
limits the versatility of this method. In addition, there is a need for specific 
fluorescently labeled proteins, which makes it difficult to analyze a wide variety of 
these biomolecules. These issues led us to probe the use of two-photon FCS as 
a better alternative for these experiments.  
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Figure 3.6. Schematic showing GNR with silica shell and a silane at the surface 
of the silica (A). Molecular structure of 2-[Methoxy(polyethyleneoxy)propyl] 
trimethoxysilane (PEG) (B), N-(Trimethoxysilylpropyl) ethylenediaminetriacetate 
(Triacetic) (C), and (3-Aminopropyl) trimethoxysilane (APTMS) (D).  
 
SiO2
Silane
AuNR
A 
(3-Aminopropyl)trimethoxysilane (APTMS) 
N-(Trimethoxysilylpropyl)ethylenediaminetriacetate (triacetic) 
2-[Methoxy(polyethyleneoxy)propyl]trimethoxysilane (PEG) 
C 
B 
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Figure 3.7. (A) UV-Visible absorbance measurements of SiO2-GNRs (––), PEG-
SiO2-GNRs ( ), APTMS- SiO2-GNRs (– ), and Triacetic- SiO2-GNRs (- -). (B) 
Zeta potential measurements showing the change in overall surface charge 
based on surface chemistry.  
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 Two-photon FCS is a non-linear optical technique where fluorescence 
results from a two-photon excitation process instead of a single photon. 
Interestingly, GNRs have shown intense luminescence under two-photon 
excitation using laser pulses.42 Thus, in two-photon FCS, GNRs photon bursts 
can be monitored directly eliminating the need for extensive surface 
functionalization or specially tagged proteins. The setup for the two-photon FCs 
system is similar to the schematic shown in Figure 3.2. However, a pulse 
excitation is used in order to create a higher photon density per pulse relative to 
the average output power. The probability of absorbing two photons per 
excitation process is proportional to the mean square of the intensity. This results 
in inherent depth discrimination such that only the focal spot receives sufficient 
intensity for significant fluorescence excitation.38  
 However, our measurements have shown intense interference from what 
we believe is the GNR scattering light. Figure 3.8 (A) shows the photon counts 
for GNRs, where both optical phenomenons are noticeable. Furthermore, the 
autocorrelation curve shows two decay events at different time range (Figure 3.8 
(B)). We assumed the decay observed in the microsecond range to represent 
particle rotation whereas the decay observed in the millisecond range to be due 
to particle diffusion. Our measurements were limited to decay representing 
particle diffusion. We measured the diffusion coefficients and diameters of both 
PAA and PAH wrapped GNRs with increasing concentration of BSA (0-20 µM) 
and derived. We found no increase in diameter for both types of GNRs with 
increasing BSA concentration. The lack of any change with free GNRs or with 
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BSA led us to conclude that the signal measured is still affected by scattering 
interference decreasing the sensitivity of the system. Until we can tune the 
system to completely filter out the scattering effect of the GNRs, this method is 
not suitable for monitoring protein-GNR interactions.  
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Figure 3.8. (A) Photon counts of PAH-GNRs as a function of time resulting from 
two-photon excitation. The peak shape observed shows two different events from 
the gold nanorods, which we believe are due to both photoluminescence and 
scattering. (B) Autocorrelation curve obtained from the photon counts of the 
PAH-GNRs. The curve shows two distinct events, the first event (microsecond 
range) is attributed to particle rotation and the second event (millisecond range) 
is due to particle diffusion. We have limited our measurements to particle 
diffusion. 
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3.5 Conclusion 
 In this chapter, we investigated the potential of using spectroscopic 
techniques such as fluorescence spectroscopy and FCS to study protein-GNR 
interactions. Two significant issues were encountered in our attempts to probe 
BSA-GNRs interactions. Firstly, the need to separate free versus bound proteins 
in certain spectroscopic methods can lead to inaccuracy. In addition, varying 
GNRs surface chemistry might render the separation step even more difficult. 
The second issue is the common optical interference that is observed with GNRs 
in spectroscopic measurements. In our case, fluorescence quenching and 
scattering effects from the GNRs so far have limited our attempts at using FCS to 
quantify BSA-GNR interactions. Thus, this work highlights the need and 
challenge to overcome these issues if we are to develop a robust and versatile 
technique to accurately probe protein-GNR interactions.  
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CHAPTER 4 
 
HOMING PEPTIDE-CONJUGATED GOLD NANORODS: HOW “TARGETED” 
ARE CELLULAR UPTAKE AND PROLIFERATION? 
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4.2 Introduction 
 
Colloidal nanoparticles functionalized with targeting/therapeutic agents 
have the potential to revolutionize the diagnosis and treatment of a variety of 
medical conditions. 1-4  Gold nanoparticles (GNPs) are excellent candidates for 
theranostic applications because of their optical and photothermal properties.1,5-8 
GNPs can be synthesized in a variety of sizes and shapes, and are composed of 
a core metal that is biocompatible.1 They can thus be use to facilitate biological 
applications such as tumor imaging, photothermal tumor ablation, and drug 
delivery.9-11 Furthermore, anisotropic gold nanoparticles such as nanorods 
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(GNRs) exhibit superior optical properties over their spherical counterparts.12,13 In 
addition, the ability to perform a variety of chemistry at the nanoparticle surface 
increases their functionality.14 This provides an opportunity to influence GNR 
biological transport through rational design, potentially including the ability to 
specifically target cancerous cells.  
At present, targeted nanoparticles are engineered via surface 
functionalization with recognition moieties (antibodies,15 homing peptides,16 
oligneuclotides,17  aptamers18) that bind specific receptors on the surface of 
tumor cells.19,20 One particularly appealing target is a class of membrane-bound 
receptors called Ephrin (Eph) receptors. Eph receptors and ephrin ligands (a 
subclass of receptor tyrosine kinases) are extensively involved in the control of 
intercellular signaling processes that govern cell division and proliferation.21,22 
These Eph receptors are 10-100x over- expressed in cancer cells,23 making them 
a promising basis for the specific targeting of cancer cells by nanotherapeutics. 
Consequently, the use of ephrin ligands, as well synthetic analogs of the ligand, 
has been investigated as a mean of targeting cancer cells, and potentially 
inducing apoptosis or reducing metastasis. In 2008, Gobin et al, demonstrated 
that Ephrin-functionalized gold nanoshells could be specifically targeted to 
prostate cancer cells for enhanced photothermal therapy.19 More recently, the 
potential for Ephrin-functionalized nanoparticles to associate with cancer cells 
during metastasis and act as enhanced drug delivery vehicles has been 
demonstrated.24  
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In order to better understand the potential for ligand-modified GNRs to 
mediate cellular signaling and induce cancer cell apoptosis by targeting EphA2 
receptors overexpressed in cancer cells, in this paper we prepared gold 
nanorods functionalized with an ephrinA1 ligand mimic, known as YSA. The YSA 
peptide has previously been deployed in vitro as a homing peptide against 
prostate cancer cells (PC-3).21 This peptide was chosen for its relatively high 
binding affinity for Eph2A receptors (Kd = 187 ± 7 nM)21 and its high specificity for 
this particular receptor. YSA (N-terminus-YSAYPDSVPMMS-C-terminus) was 
linked to a polyelectrolyte polymer (polyaspartate) via a PEG linker. The 100-mer 
of polyaspartate was employed to attach the YSA-PEG-Polyaspartate to cationic 
GNRs through the electrostatic layer-by-layer deposition technique (Figure 1).25 
In parallel, a reversed version of the YSA peptide (Reversed-YSA), with the N- 
and C- terminus reversed, was used as a control (Figure 2). Previous work have 
shown that N-terminus of the ligand or Eph receptor at the extracellular level are 
critical in ligand-receptor binding compared to the C-terminus.26-28  
To the best of our knowledge, our approach to functionalize nanoparticles 
with biomolecules via electrostatic interaction is rarely (if any) described in the 
literature compared to approaches using covalent attachment or direct physical 
adsorption of ligand to the surface of nanoparticles. After appropriate 
characterization, we investigated the interaction of the YSA- and Reversed-YSA-
GNRs in vitro with PC-3 prostate cancer cells. YSA-functionalized gold nanorods 
potentially represent a putative multi-functional anti-cancer therapeutic in that 
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they can be used to treat cancer proliferation either simply by triggering cellular 
signaling at the Eph2A receptors or by photothermal remediation if necessary.  
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Figure 4.1. Schematic showing the polyelectrolyte wrapping process at the 
surface of the CTAB-GNRs with the anionic YSA-poly(Asp) ligand. The ligand 
contains three specific regions: a polyaspartate region (100 residues) coupled to 
a PEG linker and terminated in the YSA peptide. The ligand is attached to the 
cationic GNRs by taking advantage of electrostatic interactions.  
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Figure 4.2. Schematic showing the arrangement of the YSA peptide versus the 
control version where the C and N terminus are reversed at the GNR surface.  
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4.3 Experimental section 
 
4.3.1 Materials. Chloroauric acid (HAuCl4 .3H2O, 99.9%), sodium borohydride 
(NaBH4, 99%), silver nitrate (AgNO3, 99+%), cetyltrimethylammonium bromide 
(CTAB, 99%, Sigma Ultra), sodium chloride, and ascorbic acid (99+%) were 
obtained from Sigma-Aldrich and used as received. Phosphate buffer saline 
(PBS) used was from Lonza. The MTS assay solution was purchased from 
Promega. Dialysis cassettes (20K MWCO) were purchased from Thermo 
Scientific.  All GNP solutions were prepared with purified 18 M.Ω water. 
Glassware was cleaned with aqua regia and rinsed thoroughly with deionized 
water. PC-3 and HDF cell lines were purchased from ATCC. Cellular media, 
DMEM supplemented with 4 mM 1-glutamine, 1% streptomycin, 1% penicillin, 
and 10 % fetal bovine serum (FBS) and Ham’s F12K media supplemented with 4 
mM 1-glutamine, 1% streptomycin, 1% penicillin, and 10 % fetal bovine serum 
(FBS) were prepared by the Cell Media Facility at the University of Illinois at 
Urbana-Champaign. The peptides were synthesized by the Carver Biotechnology 
Center Protein Sciences Facility at the University of Illinois at Urbana-
Champaign.  
 
4.3.2 Instrumentation. Absorption spectra of GNRs were taken on a Cary 500 
scan UV-vis-NIR spectrophotometer. Zeta potential measurements were 
performed on a Brookhaven Zeta PALS instrument. Absorbance measurements 
for the MTS were taken on a Spectramax Plus 384 plate reader from Molecular 
Devices. GC-MS analysis was performed using an Agilent 6890 gas 
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chromatograph equipped with an Agilent 5973 mass selective detector. TEM 
images were taken using a Hitachi H600 microscope at 75 kV. ICP-MS analysis 
was performed with a PerkinElmer Elan DRCe instrument ran in normal mode.  
 
 
4.3.3 Gold nanorod synthesis. Anisotropic gold nanoparticles were prepared 
using simple wet methods in the presence of the surface capping agent 
cetyltrimethylammonium bromide (CTAB) as previously described.13,25 A solution 
of 2.5 × 10-4 M HAuCl4 was prepared in 0.1 M aqueous CTAB in 50 mL centrifuge 
tube. NaBH4 (600 µL, of a 10 mM stock solution) was added to the gold/CTAB 
solution (10 mL) with vigorous stirring for 10 min with the help of a stir bar. The 
resulting seed particles (~3 nm) were used for the synthesis of both short. For 
gold nanorods (A.R. 4) the following were added in order to a conical flask: CTAB 
solution (95 mL of a 0.1 M stock solution), silver nitrate solution (1 mL of a 10 
mM stock solution), and HAuCl4  (5 mL of a 10 mM stock solution). An aqueous 
solution of ascorbic acid (0.55 mL of a 0.1 M stock solution) was then added with 
gentle mixing. Finally, the gold seed solution (0.12 mL) was added and mixed. 
The solution was left undisturbed overnight. The colored GNRs solution was 
purified by centrifugation (2X) to remove excess CTAB.  
 
 
4.3.4 Gold nanorods functionalization with YSA-PEG-Poly(Asp) and 
Reversed-YSA-PEG-Poly(Asp). The peptides were link to Poly(Asp)100 using a 
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PEG linker in the presence of the crosslinking reagent S-4FB (Solulink). YSA-
PEG5-Poly(Asp)100 and Reversed-YSA-PEG5-Poly(Asp)100 were coated to the 
surface of the synthesized CTAB-GNRs using the polyelectrolyte wrapping 
method.25 0.6 mL of 5 mg/mL of either polyelectrolytes was added to 3 mL 
CTAB-GNRs, along with 0.3 mL of 10 mM NaCl. Solutions were incubated for 12 
hours at 4° Celsius. The surface-wrapped GNRs were purified at 5500 RCF for 
30 minutes. Samples were then dialyzed for 24 hours in 20K MWCO dialysis 
cassettes. UV-Vis absorbance and zeta potential measurements were used to 
characterize the functionalization process and determine particle concentration.  
 
4.3.5 Quantification of peptide per GNR obtained by GC-MS. To quantify the 
amount of adsorbed peptide to the gold nanorod surface, CTAB-GNRs were 
coated with YSA- and Reversed-YSA-polyelectrolytes. Controls, which were free 
of GNRs, were also prepared. The supernatant, the part of the solutions 
containing only free peptide (leftover), was collected after repeated centrifugation 
(3X) at 14,000 rpm for 10 minutes. This repeated process ensured that the 
supernatant is free of GNRs. Acid hydrolysis was used to digest free peptide 
present in the supernatant into its monomeric units.29 This was done by mixing 
0.2 mL of the supernatant/control with 0.8 mL of deionized water and 1 mL of 
HCL (12 N). The resulting solutions were heated for 36 hours at 120°C. Finally, 
200 microliters of each sample and control were dried using a centrifugal 
evaporator. A 10 µL of the internal standard (L-p-chlorophenylalanine, Science 
Lab.com, Inc, Houston, TX, USA; 1 mg/mL) was added to each extract and the 
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samples were dried again. 100 µL of water, 100 µL of ethanol/pyridine (4:1), and 
50 µL of ethyl chloroformate (ECF) (Aldrich, USA) were added to each dried 
sample, and the mixture was vortexed for 3-5 seconds.30,31 After 20 minutes, 150 
µL of dichloromethane and NaCl (ca. 10 mg) were added and samples were 
thoroughly shaken for extraction. This upper phase was subjected to GC-MS 
analysis. The obtained ethoxycarbonyl-ethyl esters were analyzed on Agilent 
6890 gas chromatograph equipped with an Agilent 5973 mass selective detector 
(Agilent Inc, Palo Alto, CA).  5 mL of sample were injected in a splitless mode, 
and analyzed on a 15 m Zebron ZB-FFAP column with 0.25 mm I.D. and 0.25 
mm film thickness (Phenomenex, Torrance, CA).  Injection port and interface 
temperature were set at 250 ºC, and the ion source was set to 230 ºC.  The 
helium carrier gas was set at a constant flow rate of 1.6 mL min-1.  The oven 
temperature program was as the following: 5 min isothermal heating at 100ºC, 
increase at the rate of 10 ºC min-1 to 260ºC for the final 9 min.  The mass 
spectrometer was operated in positive electron impact mode (EI) at 69.9 eV 
ionization energy with an m/z 50-800 scan range.  The spectra of all 
chromatogram peaks evaluated using the HP Chemstation (Agilent, Palo Alto, 
CA, USA) and AMDIS (NIST, Gaithersburg, MD, USA) programs. Identification 
and quantification were performed using the mass spectra obtained from the 
authentic standards and additionally confirmed with NIST08 and/or W8N08 
libraries (John Wiley & Sons, Inc., USA). To allow comparison between samples, 
all data were normalized to the internal standard (L-p-chlorophenylalanine). 
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Calibration curves were generated with concentrations of 100, 75, 50, 20, 10, 5, 
2, 1, 0.5 µg ml-1 for each target compound. 
 
4.3.6 Peptide-functionalized GNRs stability in cell media. In order to test the 
GNR stability in PC-3 cell media, a small aliquot of the functionalized GNRs 
solution was added to the cell media and incubated at 37 °C. UV-vis absorbance 
measurements of the GNRs in cell media were taken at specific time points from 
0 to 24 hours. These spectra were analyzed to determine the extent of 
aggregation.  
 
4.3.7 Cell culture growth and maintenance. For this project, prostatic 
adenocarcinoma adult human cells (PC-3), along with human dermal fibroblast 
cells (HDF) were chosen. PC-3 cells overexpress the ephrinA2 receptor. HDF 
cells were grown in DMEM supplemented with 4 mM 1-glutamine, 1% 
streptomycin, 1% penicillin, and 10% fetal bovine serum (FBS).  PC-3 cells were 
grown in Ham’s F12K media supplemented with 4 mM 1-glutamine, 1% 
streptomycin, 1% penicillin, and 10% fetal bovine serum (FBS).  Cells were 
detached from culture with trypsin (0.05%) and EDTA (0.02%) and re-suspended 
in proper media for passaging in wells, flasks, or slides. A hemocytometer was 
used for cell counting.  
 
4.3.8 PC-3/HDF cells dosing with peptide functionalized GNRs. Both PC-3 
and HDF cells were plated in 75 cm2 rectangular canted neck cell culture flasks 
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with vented caps and allowed to reach ~80% confluency. Both YSA-GNRs and 
Reversed-YSA-GNRs at concentrations of 0.1 and 0.5 nM were used to dose 
cells. Cells were incubated with the GNRs for 2 hours. After incubation, cells 
were washed with PBS buffer (2x), split using 0.05% trypsin and collected by 
centrifugation. The collected pellet of cells was redispersed in 5 mL of media and 
the cells clumps were broken down using suction to cause an up and down 
movement of the liquid with a 10 mL pipette tip. The homogeneous solution was 
then diluted to 15 mL with media making what we called solution A. 5 mL of 
solution A was further diluted to a volume of 15 mL, called solution B (~30,000 
cells/mL), and used to plate the PC-3/HDF cells in a 6 well plate for ICP-MS 
analysis. To do this, 1 mL of the solution B was added to each well plus 1 mL of 
fresh media making a final volume of 2 mL. This results in a cell density of 
~15,000 cells/mL. Then, another 5 mL of solution A was diluted to 30 mL to make 
solution C, used for the cytotoxicity study. For the cytotoxicity study, 200 µL of 
solution C was added to each well of a 96 well plate. Finally, the last 5 mL of 
solution A was diluted to 12 mL and plated into a new cell culture flask for later 
use.  
 
4.3.9 Cytotoxicity study in the presence of YSA- and Reversed-YSA-GNRs. 
We used a MTS assay to determine the viability of cells after incubation with 
GNRs and also other components that might be present in the nanorod solution. 
This technique is a colorimetric assay for monitoring the mitochondrial activity of 
cells. MTS is bioreduced by cells into a formazan product and its absorbance is 
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measured at 490 nm.  In our work, we used dimethyl sulfoxide as the 
solubilization solution.  The assay was carried in a 96-well plate and absorbance 
at 490 nm was measured to quantify the amount of reduction that occurs which is 
directly related to cell mitochondrial activity. 
 
4.3.10 Quantitation of GNR uptake by ICP-MS. We used inductively coupled 
plasma mass spectrometry (ICP-MS) to quantify the uptake of GNRs into PC-3 
cells. Following incubation at 37°C, cells were thoroughly washed with PBS 
buffer to remove excess particles, treated with trypsin, and redispersed in 1 mL 
of buffer. We used a hemocytometer to count the number of cells, and then 
sonicated the solutions for 2 hours to completely dissolve the cells membranes. 
Gold nanorods (associated with cells) were dissolved using 0.4 mL of aqua regia 
(3:1, HCl: HNO3) for a period of 2 hours. The solution was then diluted to 5 mL 
with deionized water. The samples were then submitted to the Microanalysis 
Laboratory for ICP-MS analysis.  
 
4.3.11 Proliferation assay of PC-3 cells. We studied the proliferation of PC-3 
cells in the presence of YSA-GNRs, Free YSA, and CTAB-GNRs. Cells were 
plated in 24-well plates at a density of 20,000 cells/mL. After 24 hour of 
incubation time, cells were dosed respectively with YSA-GNRs (0.1 nM), CTAB-
GNRs (0.1 nM), Free YSA (1 and 100 µM), and media (control). Proliferation was 
measured over a period of 6 days by counting the number of cells in each well at 
the specific time points.  
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4.3.12 Competitive uptake  studies: Free YSA versus YSA-GNR. PC-3 cells 
were plated and exposed to a solution containing free YSA peptide (1 mM) and 
YSA-GNRs (0.1 nM). A control solution with only YSA-GNRs (0.1 nM) was used 
in parallel. After 2 hours of incubation, the media above the PC-3 cells was 
removed, and the cells were washed twice with PBS buffer. The extent of YSA-
GNR uptake both in the presence and absence of free peptide was then 
determined by ICP-MS.  
 
4.3.13 Transmission electron microscopy (TEM) imaging of PC-3 cells and 
GNRs. PC-3 cells were plated at 50,000 cells/mL in 6-well plates and incubated 
for 48 hours until confluency was reached. The cells were then dosed with both 
YSA-GNRs and Reversed-YSA-GNRs at a final concentration of 0.1 nM. Cells 
were then washed, trypsinized, and redispersed in Karnovsky’s fixative after 2 
and 24 hours of incubation time. Cells and GNRs were then centrifuged, the 
pellet was embedded using Osmium, Potassium Ferrocyanide, Uranyl Acetate, 
dehydrated with ethanol and acetonitrile, and embedded in an epon mixture ( 
Lx112 - Ladd, Inc), polymerized, and sectioned at 60-100 nm using a diamond 
knife and a Reichart ultramicrotome.  Sections were placed on copper grids and 
stained with Uranyl Acetate and Lead Citrate.  Imaging was done on an Hitachi 
H600 microscope at 75KV, and photographed with film. 
 
4.4 Results and Discussion 
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 The potential of functionalized GNRs as hybrid nanotherapeutics to bind 
specifically and influence the growth of PC-3 cancer cell lines in vitro was 
investigated. YSA-GNRs and Reversed-YSA-GNRs were prepared first by 
synthesizing the YSA and Reversed-YSA peptides, covalently linking them to 
polyaspartate through the N- or C-terminus, and finally loading the peptide 
complexes at the GNRs surface using the previously reported layer-by-layer 
functionalization procedure.25 A series of assays were performed to characterize 
and probe the efficiency of using the YSA-functionalized GNRs as a 
nanotherapeutics system.  
 CTAB-GNRs were successfully functionalized with both YSA- and 
Reversed-YSA-polyelectrolytes using the polyelectrolyte layer-by-layer 
technique.25 The success of the synthesis process was assessed by proper 
characterization and quantification of the number of peptide loaded on each 
GNR. UV-vis absorbance measurements of the GNRs were taken before and 
after functionalization. The longitudinal plasmon peak of the gold nanorods is 
highly sensitive to changes in particle stability and large broadening of the 
plasmon peak is expected when aggregation occurs.32,33 From the UV-Vis 
measurements (Figure 4.3 A), limited peak broadening is observed, thus minimal 
aggregation after polyelectrolyte wrapping in the presence of both version of the 
peptide occurs. We also monitored the change in overall surface charge of the 
GNRs by taking zeta potential measurements before and after the layer-by-layer 
reaction. Since both versions of the peptide are covalently linked to a negatively 
charged poly (aspartate) chain, a reverse in overall surface charge is expected. A 
	   113	  
change from ~+30 mV for CTAB-GNRs to ~ -20 mV and ~ -30 mV for YSA- and 
Reversed-YSA-GNRs respectively is observed. These results confirm the 
presence of both YSA- and Reversed-YSA-polyelectrolytes at the GNR’s surface 
(Figure 4.3 B).   
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Figure 4.3. (A) UV-Vis absorbance spectra of CTAB-GNRs (––), Reversed-YSA-
GNRs (- -), and Reversed-YSA-GNRs () showing minimal peak broadening. (B) 
Zeta potential measurements for CTAB-GNRs, Reversed-YSA-GNRs, and YSA-
GNRs.  
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After confirming the successful characterization of the GNRs with both 
version of the peptide, quantification of peptide per particle was performed using 
gas chromatography coupled with mass spectrometry (GC-MS). To do so, the 
supernatant from the polyelectrolyte reaction was collected by centrifugation to 
quantify the amount of free YSA-polyelectrolyte after peptide digestion to amino 
acids using acid hydrolysis and an internal standard for accurate quantification. 
By subtracting the amount of aspartic acid detected in supernatants from the 
amount detected in control solutions (no GNRs), the amount of peptide bound to 
GNRs was calculated. The amount of YSA-polyelectrolyte and Reversed-YSA-
polyelectrolyte bound to the GNR was to found to be 38.8 ± 7.2 µg/mL and 27.27 
± 4.8 µg/mL respectively. This corresponds to about 4300 ± 800 and 2300 ± 500 
peptides/GNR.  
 The ability of theranostic GNRs to maintain their properties after entering 
biological systems is an essential consideration in their design and synthesis. 
Prior to incubating the YSA- and Reversed-YSA-GNRs with PC-3 cells, we 
investigated their stability in PC-3 cell media over an extended period of time by 
looking at changes in their absorbance spectra (Figure 4.4). Results confirmed 
that the functionalized GNRs remained stable in the media after 24 hours of 
incubation. However, the formation of a third peak around 1000 nm suggests the 
formation of particle aggregates over time. Reversed-YSA-GNRs showed 
somewhat a better stability in cell media, but the formation of a third peak in the 
same region was also noticed over time. The evolution of a protein corona can 
cause nanoparticle aggregation in biological fluids.12 Therefore, all uptake 
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experiments were done at t= 2 h, a time range corresponding to minimal GNR 
aggregation.  
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Figure 4.4. UV-Vis spectra showing the absorbance of YSA-GNRs (A) and 
Reversed-YSA-GNRs (B) incubated at different time points (–– 0 h), (- - 3 h), ( 
6 h), (−  24 h) in PC-3 cell culture media at 37°C. At t = 0 particle are in water. 
The formation of an extra peak at about 1000 nm suggests GNR aggregation due 
to protein adsorption.  
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 The uptake of both YSA-GNRs and Reversed-YSA-GNRs in vitro was 
studied in order to probe the specificity of YSA-GNRs for EphA2 receptors. 
Inductively coupled plasma mass spectrometry (ICP-MS) was used to detect Au 
atoms associated with the cancerous cells after dosing with GNRs. The amount 
of Au atoms detected was converted to amount of GNRs based on the 
nanoparticle dimensions. Results showed that YSA-GNRs are taken up much 
more than Reversed-YSA-GNRs by PC-3 cells, confirming the specific interaction 
of the YSA-functionalized GNRs to the EphA2 receptors at the surface of the PC-
3 cells (Figure 4.5). Furthermore, their uptake in normal cells (HDF) was also 
investigated (Figure 4.6). The EphA2 receptors are less expressed in normal 
cells,19 thus lower concentration of GNRs are expected to be associated with 
HDF cells compare to PC-3 cells. Indeed, we found the amount of GNRs to be 
uptaken by HDF cells to correspond to about half of the amount uptaken by PC-3 
cells. Interestingly, both cells line uptake the YSA-GNRs more abundantly 
compare to the reversed version (Reversed-YSA-GNRs). This observation is 
logical since EphrinA2 receptors, even though less abundant, are still present in 
HDF cells28 and increase the affinity of YSA-GNRs for the cell surface, thus 
resulting in higher uptake.  
 We also studied the viability of PC-3 cells when dosed with different 
concentration of both YSA- and Reversed-YSA-GNRs using a MTS assay. We 
found to cells to remain viable after being incubated for a period of two hours with 
GNRs. Both YSA-GNRs and reversed YSA-GNRs between concentrations of 
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0.01-0.1 nM did not alter the viability of the PC-3 cells (same concentration range 
used in the GNR uptake studies) (Figure 4.7).  
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Figure 4.5. Quantification of gold nanorod uptake by PC-3 cells via ICP-MS. The 
two concentrations correspond to those of initial YSA-conjugated GNRs (per 
particle) and Reversed-YSA-GNRs for ~40,000 cells/mL of PC-3 cells after 2 h of 
incubation.  
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Figure 4.6.  GNR uptake results for PC-3 cells versus HDF cells using ICP-MS. 
YSA-GNRs and Reversed-YSA-GNRs concentration were both 0.05 nM. The 
concentration correspond to that of initial YSA-conjugated GNRs (per particle) 
and Reversed-YSA-GNRs for ~40,000 cells/mL of either HDF or PC-3 cells after 
2 h of incubation.  
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Figure 4.7. Cellular viability results for YSA-GNRs and Reversed-YSA-GNRs in 
PC-3 cells at sub-lethal concentrations using a MTS assay after t= 2 h.  
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 It is suggested that the binding of the natural ligand, ephrinA1, to EphA2 
receptors lead to their phosphorylation and down-regulation.22 Activated EphA2 
receptors thus start signaling events that lead to inhibition and reversal of 
malignant traits in the cell such as proliferation and invasiveness.34 However, in 
pathologic tissues the EphA2 receptor is up-regulated and the lack of ligand to 
bind and activate those receptors lead to tumor metastasis and poor prognosis 
leading to cell proliferation.23 It has been shown that the YSA peptide functions 
similarly to the ephrinA1 ligand.21 Thus, we studied the effect of the binding of the 
YSA peptide to the EphA2 receptors by looking at the proliferation of PC-3 cells 
after controlled dosage. CTAB-GNRs, YSA-GNRs, and free YSA ligand were 
added to PC-3 cell cultures and incubated over a period of six days. Cells in 
which the culture media was free of GNRs were used as control. Cells were 
counted at day 1, 2, 3, and 6. Results show that CTAB-GNRs decrease the 
proliferation of PC-3 cells. This is due to the high toxicity level of the bare GNRs 
due to the presence of CTAB at their surface.35 Furthermore, PC-3 cells in the 
presence of YSA-GNRs showed a slight decrease in cell proliferation. This might 
suggest a decrease or a change in cellular response after ligand-EphA2 receptor 
binding due to the presence of the YSA-GNRs. In order to provide a better 
explanation for this, the effect of free YSA versus YSA-GNRs was also studied. 
PC-3 cells were incubated with free YSA (1 and 100 µM) and the rate of 
proliferation of the cells was also monitored. As for the YSA-GNRs, no significant 
difference was observed over a 3-day period, however after 6 days of incubation 
the proliferation rate decreased significantly in the presence of free YSA 
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especially at a high concentration of 100 µM. These results confirm, to a certain 
degree, a decrease in proliferation of PC-3 cells in the presence of YSA-GNRs 
after binding EphA2 receptors at cell’s surface. In addition, the decrease in cell 
proliferation is not immediate; a certain length of incubation time is necessary 
before a noticeable difference is observed. These observations render it difficult 
to make a conclusion on the effect of the YSA-GNRs on tumour cells. However, 
the simple wrapping method employed in this work to associate the peptide with 
the GNRs and the increased binding specificity obtained toward tumour cells 
overexpressed with EphA2 receptors, opens the door to the design of 
polyelectrolytes combining the YSA peptide and established cancer therapeutic 
molecules to efficiently target and decrease tumor growth in vivo. Wang et al, 
have already shown that it is possible to conjugate the drug paclitaxel at the C-
terminal of the YSA peptide to create an efficient targeting and therapeutic 
molecule.28 Furthermore, photothermal therapy can also be used to induce 
temperature jumps in tissue located a few millimeters below the skin when dosed 
with GNRs.9  
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Figure 4.8. Proliferation of PC-3 cells in culture media free of GNRs, culture 
media with 0.1 nM CTAB-GNRs, culture media with 0.1 nM YSA-GNRs, and 
culture media with free YSA (1 µM and 100 µM).  
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 To better understand the interaction of YSA-GNRs with the EphA2 
receptors at the surface of the cells, we probed for changes in their uptake in the 
presence of free YSA at high concentration. A solution containing a mixture of 
YSA-GNRs (0.1 nM) and free YSA peptide at high concentration (1 mM) was 
used to dose PC-3 cells for a period of 2 hours and GNR uptake was analyzed in 
both cell media and buffer. In an ideal system we expect the free YSA peptide to 
bind to the EphA2 receptors at a much higher rate compare to the YSA-GNRs 
due to the higher concentration of free YSA present. Thus, EphA2 receptors at 
the surface of the cells should be blocked and the YSA-GNRs binding to these 
receptors should be limited which would lead to a decrease in uptake of the 
functionalized GNRs. However, when PC-3 cells were dosed and the GNRs 
digested into Au atoms for ICP-MS analysis, the amount of GNRs uptaken by 
PC-3 cells was found to be at similar level for both solution containing YSA-
GNRs plus free YSA and YSA-GNRs only (Table 4.1). These results suggest that 
the free YSA did not affect the uptake of the YSA-GNRs within the cells. One 
explanation for this might be the independent uptake of GNRs by cells regardless 
of their interaction with the EphA2 receptors. In other words, the YSA-receptor 
binding is not involved in the GNRs uptake but only help the gold nanomaterial to 
associate with the cell’s surface. It has been previously shown that GNRs free of 
homing peptide are still uptaken by cells arising from cellular recognition of 
proteins in the cellular media via receptor-mediated endocytosis.35 However, our 
results show uptake even in the presence of buffer, where no protein is present, 
indicating that the cells might uptake GNRs using a different mechanism. We 
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believe any increase in the density of the GNRs at the cell’s surface can lead to 
an increased uptake. We repeated the experiment in phosphate buffer saline 
(PBS) buffer instead of cell media. It is expected that the YSA-GNRs in buffer will 
have lower stability and form further aggregates, which increases their size, thus 
their accumulation at the cell surface leading to higher uptake in the cells. About 
a 10-fold increase in uptake was observed in buffer compare to cell media 
proving the importance of GNRs sedimentation and increased concentration at 
cell’s surface during the uptake process.  
 
Table 4.1. YSA-GNRs uptake per cell with or without free YSA in both media and 
PBS buffer.  
 In media (GNRs/cell) In buffer (GNRs/cell) 
YSA-GNRs + free YSA (1.46 ± 0.1) × 105 (9.47 ± 1.9) × 105 
YSA-GNRs (1.33 ± 0.2) × 105 (10.90 ± 2.6) × 105 
 
 
 Bio-TEM analysis, which involves electron imaging of fixed PC-3 cells 
previously incubated with GNRs, shows YSA-GNRs and Reversed-YSA-GNRs to 
be uptaken into the PC-3 cells by similar pathway. PC-3 cells were dosed with 
both YSA-GNRs and Reversed-YSA-GNRs at a final concentration of 0.1 nM. 
Cells were then washed, trypsinized, and redispersed in fixative at two different 
incubation time (2 and 24 hours). Bio-TEM imaging revealed that the 
functionalized GNRs are taken up into the PC-3 cells in perinuclear fashion 
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trapped in vacuoles. Vacuoles were on average ~0.5 µm diameter wide 
dependent on the number of GNRs entrapped. About 20-60 YSA-GNRs per 
vacuole after a 2-hour incubation period and about 200-500 YSA-GNRs per 
vacuole after a 24-hour period were observed. For Reversed-YSA-GNRs about 
10-20 GNRs per vacuole were observed after a 2-hour period and 50-100 GNRs 
per vacuole after a 24-hour period. From the Bio-TEM results it is evident that 
YSA-GNRs were more abundant in the cells compare to the reversed version. 
However, there is no sign of different localization within the cells between the two 
versions of the functionalized GNRs. Cells perceive the nanomaterial, possibly 
due to their large size, as a foreign object and as protection mechanism entrap 
GNRs into vacuoles preventing them from reaching the nucleus. We did not 
observe a change of GNRs localization with longer period of incubation (24 h), 
only an increase in uptake of GNRs.  
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Figure 4.9. Transmission electron micrographs of PC-3 cells. PC-3 cells (50,000 
cells/mL) were incubated with YSA-GNRs at a concentration of 0.1 nM at t= 2 h 
(A) and t= 24 h (B and C). PC-3 cells incubated with 0.1 nM Reversed-YSA-
GNRs at t= 2 h (D) an t= 24 h (E and F). Scale bar: A= 1 µm, B, D, and E= 0.5 
µm, C and F= 5 µm.  
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4.5 Conclusion  
This work has shown the successful functionalization of GNRs with a 
mimetic peptide with specific affinity for EphA2 receptors using an extremely 
simple and efficient wrapping technique based on attractive electrostatic 
interaction between the peptide-complex and the surface of the GNRs. 
Furthermore, a reversed version of the peptide was used as an ultimate control. 
Results show that the YSA-GNRs have higher uptake compare to Reversed-
YSA-GNRs. We believe this is due to the increase affinity of YSA-GNRs for 
EphA2 receptors, which are up regulated at the surface of cancerous PC-3 cells, 
thus increasing the local concentration of YSA-GNRs at the PC-3 cell surface. 
The functionalization of the GNRs with a targeting peptide via electrostatic 
interaction offers a promising platform for therapeutic applications. However, 
based on our proliferation results, it remains inconclusive that the YSA 
functionalized GNRs can effectively suppress the proliferation of the PC-3 cells 
through EphA2 receptors binding and activation. However, this work opens the 
door for facile designs combining the targeting ability of the YSA peptide to 
cancer cells, established cancer drug therapeutics for tumor growth suppression, 
and gold nanorods as a carrier that can provide enhance cellular interaction, 
photothermal therapy and tracking capabilities.  
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 CHAPTER 5 
 
NONLINEAR OPTICAL RESPONSE OF GOLD NANORODS FOR 
MOLECULAR-LEVEL IMAGING IN VIVO 
 
 
5.1 Notes and Acknowledgments 
 The author would like to acknowledge Yuan Liu and Prof. Stephen 
Boppart for the assistance with the non-linear optical imaging experiments and 
interpretation and Dr. Edmond Chow from the Micro and Nanotechnology 
Laboratory at the University of Illinois at Urbana-Champaign for preparing the 
GNR patterns. 
 
5.2 Introduction 
 The recent advances made in the field of nanotechnology have led to the 
synthesis of many different types of nanoparticles for applications in chemical 
sensing, biological imaging, and medical therapeutic applications.1-5 However, 
the study and control of their fate in vivo remains a challenge.  Gold 
nanoparticles, which can be made biocompatible by modifying their surface 
chemistry,6 are interesting due to their shape-dependent optical properties 
allowing for many different sensing and imaging modalities.7,8 In particular, gold 
nanorods (GNRs) absorb and scatter light strongly in the near-infrared portion of 
the electromagnetic spectrum and thus can be imaged at the single-particle level 
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by elastic light scattering, two-photon luminescence (TPL), and other imaging 
modalities.9-11 Furthermore, functionalized GNRs can specifically target 
cancerous biomarkers and efficiently convert light to heat for photothermal 
therapy.12 While GNRs have shown promising potentials in biophotonic imaging, 
understanding their physical and chemical properties for in vivo applications is an 
ongoing research challenge.  
 GNRs are 20-200 nm, which is smaller than the wavelength of light. Upon 
incoming electromagnetic radiation, a coherent oscillation of electrons in the 
conduction band gives rise to intense plasmon absorption and scattering, known 
as localized surface plasmon resonance (SPR).13,14 SPR depends on factors 
such as shape, size, state of aggregation, and the local refractive index of the 
media surrounding the GNRs.14 Different nonlinear optical signals from gold 
nanostructures have been reported, including two-photon luminescence (TPL), 
second harmonic generation (SHG), and third harmonic generation (THG), by 
illuminating the samples with ultrafast pulses.15-17 However, the optical response 
of GNRs to different pulse shapes has not been studied. Pulse shaping can been 
employed for selective excitation, contrast enhancement, and information 
extraction.18 In the case of GNRs, by modulating the illuminating pulses, their 
nonlinear optical processes can be potentially controlled in order to improve their 
imaging capabilities in tissues in vivo.  
 In this work, the TPL response of GNRs to different pulse shapes was 
investigated. Pulses from a fiber supercontinuum are phase and amplitude 
shaped by a spatial light modulator for generating different nonlinear optical 
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signals. The TPL signal with respect to different spectral phases was monitored. 
The variation of TPL intensity with respect to spectral phase suggests the 
controllability of the nonlinear optical response of GNRs. 
 
5.3 Experimental Section 
5.3.1 Materials. Chloroauric acid (HAuCl4 .3H2O, 99.9%), sodium borohydride 
(NaBH4, 99%), silver nitrate (AgNO3, 99+%), cetyltrimethylammonium bromide 
(CTAB, 99%, Sigma Ultra), ascorbic acid (99+%), poly(acrylic acid, sodium salt) 
(PAA, MW ~15,000 g/mol, 35% wt in water), poly(allylamine hydrochloride) (PAH, 
MW ~15,000 g/mol, and poly(methyl methacrylate) (PMMA,MW ~120,000 g/mol) 
were obtained from Sigma-Aldrich and used as received.  
 
5.3.2 Instrumentation. Absorption spectra were taken on a Cary 500 scan UV-
vis-NIR spectrophotometer. Transmission electron microscopy (TEM) data were 
obtained with a Joel 2100 Cryo electron microscope operating at 200 kV. TEM 
grids were prepared by drop casting 10 µL of purified gold nanoparticle solution 
on the TEM grids and drying them in air. Zeta potential measurements were 
performed on a Brookhaven Zeta PALS instrument. The TPL measurements 
were done as follow: pulses from a Yb:KYW laser (femtoTRAIN IC-1040-3000, 
High Q Laser, Austria) are coupled into a nonlinear PCF (NL-1050-NEG-1, NKT 
Photonics, Denmark) for supercontinuum (SC) generation. The SC is shaped by 
a multiphoton intrapulse interference phase scan (MIIPS) assisted pulse shaper 
(MIIPS box 640, Biophotonics Solutions) and guided into a home-built upright 
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microscope for imaging. Transform-limited (TL) pulses of 900-970 nm are used 
for TPL imaging, and TL pulses of 1100-1160 nm are used for SHG and THG 
imaging. TL pulses are employed for efficient signal generation. Multimodal 
imaging is performed by sequentially imaging the samples with different incident 
pulses and emission filters (TPL: 485nm long-pass; SHG: 562 ± 40 nm; THG: 
376 ± 20 nm). To monitor the TPL response to pulse shapes, a quadratic phase 
scan from -5000 fs2 to +5000 fs2 with 1000 fs2 interval for two polarizations is 
performed; an image is acquired for each phase step. 
 
5.3.3 Gold nanorod synthesis (aspect ratio= 4). Gold nanorods were prepared 
using simple wet chemical method in the presence of the surface capping agent 
cetyltrimethylammonium bromide as previously described.9,19-21 A solution of 2.5 
× 10-4 M HAuCl4 was prepared in 0.1 M aqueous CTAB in a 50 mL centrifuge 
tube. NaBH4 (600 µL, of a 10 mM stock solution) was added to the gold/CTAB 
solution (10 mL) with vigorous stirring for 10 min with the help of a stir bar. The 
resulting seed particles (~3 nm diameter) were used for the synthesis of both 
short and long gold nanorods. To prepare gold nanorods (aspect ratio 4) the 
following were added, in order, to a conical flask: CTAB solution (95 mL of a 0.1 
M stock solution), silver nitrate solution (1.2 mL of a 10 mM stock solution), and 
HAuCl4  (5 mL of a 10 mM stock solution). An aqueous solution of ascorbic acid 
(0.55 mL of a 0.1 M stock solution) was then added with gentle mixing. Finally, 
the gold seed solution (0.12 mL) was added and mixed. The solution was left 
undisturbed overnight. The colored gold nanorod solution was purified by 
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centrifugation (2X) to remove excess CTAB. We used UV-visible absorbance and 
transmission electron microscopy to confirm the gold nanorods size and shape.  
 
5.3.4 Gold nanorod encapsulation in PMMA. A solution containing 20 wt% 
PMMA in acetone was added to a solution of PAH-capped nanorods in acetone 
(1:1 v/v ratio). Final concentration of GNRs was 0.01 nM, calculated from dilution. 
The solution was drop cast onto glass and a coverslip was placed on top. After 
drying, a PMMA film with encapsulated GNRs was left behind.  
 
5.3.5 Fabrication of gold nanorod pattern. Gold nanorod patterns were 
fabricated by electron beam lithography on indium tin oxide (ITO) surface at the 
Micro and Nanotechnology Laboratory (MNTL) at the University of Illinois at 
Urbana-Champaign. The spacing between each GNR was 2 µm and the GNR 
dimensions were 120 nm in length and 20 nm in diameter. The GNRs were 
arranged by set 16 per square and aligned at varying angles from 15-180 
degrees. Each square represented an alignment angle.  
 
5.4 Results and Discussion  
 GNRs exhibit two distinct plasmon bands upon absorption of light in the 
visible region of the spectrum, leading to their interesting optical properties.14 The 
longitudinal plasmon band (LSPR) of the metal corresponds to light absorption 
and scattering along the long axis of the particle whereas the transverse plasmon 
band (TSPR) relates to light absorption and scattering along the short axis of the 
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particle. The longitudinal plasmon band is more sensitive to changes in the 
GNRs environment. It was observed that field enhancements coincide with this 
plasmon.15 Indeed, an increase in TPL is observed when the excitation 
wavelength is aligned with the longitudinal plasmon absorption band.11 
 In this work, GNRs of aspect ratio 4 and LSPR at about 800 nm were 
synthesized using the seed mediated synthesis (Figure 5.1).9 Two-photon 
luminescence optical imaging of GNRs by shaped pulses was tested either by 
embedding the GNRs in poly(methyl methacrylate) PMMA or by drying GNRs 
solution on glass slide and lens tissue. To embed the GNRs in PMMA, it was 
necessary to suspend the nanomaterials in acetone instead of their usual 
aqueous environment. CTAB capped GNRs are not stable in organic solvents. 
Thus, to enhance their stability in acetone, the CTAB-GNRs were first coated 
with 2 layers of polyelectrolytes, the anionic polyacrylic acid (PAA) followed by 
the cationic polyallylamine hydrochloride (PAH) and then redispersed in 
acetone.22 The obtained PAH-GNRs were then embedded in PMMA at a 
concentration of 0.01 nM and imaged.  In the three environments tested, PMMA 
worked best since single particles were isolated in a rigid environment (Figure 
5.2). In PMMA, isolated GNRs were identified and their TPL signal was 
measured. However, drying GNRs on glass slides and lens tissues led to particle 
aggregation.  
 
 
 
	   142	  
 
 
Figure 5.1. UV-visible absorbance spectrum of GNRs of aspect ratio 4 in water 
showing a LSPR at about 800 nm.  
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Figure 5.2. TPL imaging of GNRs suspended in PMMA at a concentration of 
(0.01 nM) (A), deposited on glass slide (1 nM) (B), and on lens tissue (1 nM) (C). 
We found PMMA to work better for particle isolation at low concentration. Scale 
bar = 25 µm.   
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 Different modalities of optical signals can be generated from the GNRs 
when illuminating with different pulse shapes. In the case of TPL, the nonlinearity 
of this modality was confirmed by performing a power dependence test, as 
shown in Figure 5.3. The slope for a TPL signal to the power of the incident 
pulses in logarithmic scale was found to be 2, approximating the photon numbers 
participating in the TPL event.11 
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Figure 5.3. Power dependence of the nonlinear TPL signal for PAH-GNRs 
suspended in PMMA obtained when increasing the incident laser power. Linear 
regression analysis yielded a slope of 1.99.  
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Furthermore, the spectral phase and polarization dependence of TPL from GNRs 
was examined with GNRs in PMMA. The TPL intensity of GNRs with respect to 
spectral phase for two polarizations (parallel and perpendicular) is shown in 
Figure 5.4. The TPL signal is stronger when the polarization of the incident 
pulses is aligned parallel to the longitudinal plasmon resonance and it is weaker 
when the pulses are perpendicularly aligned to the longitudinal plasmon. An 
obvious spectral phase dependence of the TPL signal is observed for the 
polarization with stronger signal. In other words, the TPL signal shows apparent 
spectral phase dependence when the incident pulses are aligned with the 
longitudinal plasmon resonance. In some cases, when both polarizations show 
some spectral dependence, the longitudinal plasmon resonance is possibly in 
between two polarizations. The maximum TPL intensity occurs at spectral phase 
around -2000 fs2 to -3000fs2, which is close to the transform-limited pulse (TL) 
phase.  
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Figure 5.4. Spectra phase and polarization dependence of the TPL intensity from 
GNRs suspended in PMMA with (n) horizontal polarization, (u) perpendicular 
polarization, (Δ) and signal ratio between two polarizations. Spectra 1 through 3 
represent GNRs in TPL image also labeled 1 through 3 respectively.  
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 To evaluate the effect of possible photodamage, GNRs were imaged with 
a flat spectral phase, using the same power as in the phase dependence 
experiment, and for both polarizations. For most GNRs, a slow decay in TPL 
intensity was observed, which is possibly due to gradual 
photodamage/photobleach/photodeformation. In rare cases, steep increases in 
TPL intensity followed by steep decays, indicated possible GNRs deformation 
events.23,24 This type of deformation tends to occur when the polarization of the 
incident pulses is aligned with the longitudinal plasmon resonance. This feature 
agreed well with our experiments. As in the phase dependence experiment, 
deformation occurs mostly when GNRs demonstrate phase dependence, while it 
doesn’t occur for those showing no or little phase dependence.  
 Our results show variations in TPL intensity with respect to spectral phase, 
which suggests the capability of controlling the nonlinear optical response of 
GNRs. However, to fully understand the behavior of the GNRs under different 
phases and polarizations, a study is needed on specifically oriented GNRs. We 
have used electron beam lithography to create pattern of aligned GNRs via gold 
atom deposition (Figure 5.5). The angle at which the GNRs were aligned was 
varied. However, our attempt to do TPL measurements on the aligned GNRs 
yielded very low signal. It might be necessary to reduce the 2-µm spacing 
between GNRs to allow for interpaticle electric field coupling.25,26 However, at this 
moment, the minimum distance that we are able to place the GNRs apart is 200 
nm. We do not expect GNRs to couple that far apart. This experiment needs to 
be repeated with spacing a low as 10-20 nm between GNRs. We have also 
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considered other methods to align the GNRs. Previous studies have shown that it 
is possible to align GNRs in polymer composites such as poly(vinyl alcohol) 
(PVA) using a stretch-film method 27, however, our attempts at aligning GNRs in 
bulk polymer were unsuccessful due to low quality of polymer film obtained and 
particle aggregation.  
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Figure 5.5. (A) Scanning electron micrograph (SEM) of patterned GNRs oriented 
at an angle of 45° via gold deposition on an ITO glass. The spacing between 
each rod is 2 µm. (B) SEM of single GNR with a dimension of 128.5 nm in length 
and 25.5 nm in width.  
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5.5 Conclusions 
 We have shown the possibility to control gold nanorod nonlinear optical 
properties such as two-photon luminescence by varying instrumental parameters 
such as spectral phase and polarization. By controlling the TPL intensity of 
GNRs, we can prevent particle photodamage and deformation. Furthermore, the 
strong optical signal from GNRs can sometimes prevent the visualization of their 
environment both in vitro and in vivo. The ability to control nonlinear optical 
signals intensity via spectral phase and polarization variation can provide a 
robust solution to this issue thus improving the performance of GNRs in vivo for 
chemical sensing, biological imaging, and therapeutic applications.  
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CHAPTER 6 
SYNTHESIS OF GOLD NANORODS AT LOW SURFACTANT 
CONCENTRATION BY THE ADDITION OF BROMIDE IONS 
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6.2 Introduction 
 
Gold nanoparticles are of tremendous scientific interest due to their unique 
optical and photothermal properties that enable promising chemical, biological, 
and clinical applications.1 While spherical nanoparticles are easy to prepare, their 
optical properties are less attractive compared to their anisotropic counterparts 
(nanorods, nanocages, nanoprisims and others) that absorbs in the near-
infrared.2-5 
The synthesis of GNRs is conceptually simple and can be described as an 
aqueous wet-chemical, seed-mediated, surfactant-directed, and silver-assisted 
synthesis.5-7 The synthetic protocol was developed in the late 1990’s and early 
2000’s using a cationic surfactant, cetyltrimethylammonium bromide (CTAB), as 
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a shape-directing agent.8 The GNR synthesis protocol has two steps: 1) the 
preparation of gold seed nanocrystals and 2) the one-dimensional growth of 
these seeds in the presence of gold and silver ions at a high concentration of 
CTAB (0.1 M).6 A high CTAB concentration was necessary to achieve an 
excellent size and shape control of the GNR. This requirement was initially 
explained by the need of rod-shape micelles of CTAB as a soft template for the 
GNR.9,10 An alternative mechanism has been proposed, called the zipper 
mechanism, where CTAB molecules preferentially adsorb on specific crystal 
faces of the seeds limiting growth to one direction on the exposed facets.10,11 As 
the rods grow, CTAB is proposed to zip up the sides of the new rod growth, like a 
zipper, thereby continuing to limit growth in one direction. However, the exact 
mechanism of GNR formation using the standard preparation is still 
debatable.2,11,12 The importance of bromide as a counterion in the micellar 
structure of CTAB was studied using a chloride analog.12 The chloride version of 
CTAB, cetyltrimethylammonium chloride (CTAC), at 0.1 M concentration resulted 
in the formation of gold nanospheres instead of gold nanorods. Furthermore, 
GNR are not formed in the absence of trace silver ions in 0.1 M 
CTAB.{Sau:2004cn} A revised zipper mechanism of preferential adsorption of 
silver bromide species on the seed crystals was proposed.{Murphy:2005hb, 
Gao:2003fk, Murphy:kj} The chemical signature of bromide and silver ions on 
gold nanorods was seen using mass spectrometry14 and vibrational 
spectroscopy.15 This led us to the hypothesis that the high concentration of CTAB 
is not necessary to form a soft template, instead it is a source of concentrated 
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bromide ions to form GNRs. This paper details experimental evidence supporting 
this hypothesis and indicates that stable, well-defined GNR can be prepared by 
substituting 80% of CTAB in the standard protocol with simple bromide salts. 
Moreover, these results further support a zipper mechanism over a soft-template 
mechanism. 
Regardless of the mechanism, cytotoxic CTAB, when used above 
micromolar concentrations, may limit the medical and biological use of GNR. 
With this in mind, efforts to prepare GNRs with less CTAB as a greener protocol 
that also challenge important mechanistic details of GNR formation are reported 
here. 
 
6.3. Experimental Section 
 
6.3.1 Materials. Chloroauric acid (HAuCl4 .3H2O, 99.9%), sodium borohydride 
(NaBH4, 99%), silver nitrate (AgNO3, 99+%), ascorbic acid (99+%), sodium nitrate 
and sodium chlorate were obtained from Sigma-Aldrich and used as received. 
Potassium bromide was obtained from Mallinckrodt. Cetyltrimethylammonium 
bromide (CTAB, 99%, Sigma Ultra) and cetyltrimethylammonium chloride 
(CTAC) were obtained from Sigma Chemicals and used as provided. All 
solutions were prepared with purified water (18 MΩ×cm resistivity). All glassware 
was cleaned with aqua regia and rinsed thoroughly with purified water (18 
MΩ×cm resistivity). 
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6.3.2 Instrumentation. Absorption spectra were taken on a CARY 500 Scan UV-
Vis-NIR spectrophotometer. Transmission electron microscopy (TEM) data were 
obtained using a JEOL 2100 cryo transmission electron microscope operating at 
200 kV with a thermionic <001>-oriented single crystal LaB6 electron emitter and 
recorded on a Gatan UltraScan 2k × 2k charge-coupled device (CCD) camera. 
Holey formvar, carbon coated copper TEM grids (300 mesh, SPI) were used to 
prepare TEM samples by dropcasting 7 µL of the purified gold nanorod solution 
on the TEM grids and allowing them to dry in air. Cryogenic transmission electron 
microscopy (cryo-TEM) data were obtained using a FEI Tecnai G2 F30 field-
emission gun transmission electron microscope operating at 300 kV and 
recorded on at Gatan UltraScan 4k × 4k CCD camera. Cryo-TEM samples were 
prepared on 200 mesh copper TEM grids coated with a lacey carbon support film 
(SPI, Inc.) using an FEI Vitrobot. TEM grids were made hydrophilic, prior to cryo 
sample preparation, by glow discharge for one minute under reduced 
atmospheric pressure. Specifically, cryo samples were prepared by placing 3 µL 
of suspension on the grid, followed by 1 second of blotting and dwell time, each, 
before plunging into liquid ethane. Samples were then stored under liquid 
nitrogen until they were cryogenically transferred to the microscope for imaging. 
Zeta potential measurements were performed on a Brookhaven Zeta PALS 
instrument. A micro centrifuge (Eppendorf model 5418, Fisher-Thermo Electron) 
and a LabQuake® shaker (model C4152110, Barnstead-Thermolyne) were used 
in gold nanorod synthesis and purification as detailed below. 
 
	   166	  
6.3.3 Gold nanorod synthesis. Gold nanorods of varying aspect ratios were 
synthesized as previously described. A 2.5 x 10-4 M HAuCl4 solution was 
prepared in 0.1 M CTAB. 600 mL of 10 mM NaBH4 at 0 ˚C were added with 
vigorous stirring of the HAuCl4 solution and stirred for 10 min. The resulting 
nanoparticles were used as seeds in the synthesis of gold nanorods. 
In a typical synthesis, the following chemicals were combined in a 125 mL 
conical flask, in the following order, to create a growth solution. Into 95 mL of 
purified water, the appropriate amounts of CTAB and bromide salt were varied to 
create a final concentrations ranging from 0 to 0.1 M, each. Based on the desired 
aspect ratio, we varied the amount of 10 mM silver nitrate from 0 to 1 mL. Then, 
5 mL of 10 mM chloroauric acid was added to the flask. To this solution, 0.5 mL 
of 0.1 M ascorbic acid was added with gentle mixing resulting in the growth 
solution. Finally 0.12 mL of the previously prepared, gold seed suspension was 
added to initiate growth, mixed by swirling, and left undisturbed overnight (14-16 
hrs). The colored gold nanorod suspension was purified by centrifugation at 
16,873 rcf for 3 minutes, twice, to remove excess CTAB, followed by 
resuspension in purified water. 
 
6.3.4 Gold nanorod stability. The stability of gold nanorods prepared using the 
standard method (0.1 M CTAB) and nanorods prepared via the greener method 
(0.02 M CTAB and 0.08 M KBr) was assessed using the centrifugation method. 
Specifically, 1.0 mL of the GNR suspension was centrifuged at 16,873 rcf for 5 
minutes, decanted, and the resulting pellet resuspended in 1.0 mL of purified 
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water. The centrifugation and resuspension was repeated three times with Vis-
NIR spectra obtained after each centrifugation to monitor GNR aggregation. 
 
6.4. Results and Discussion 
Gold nanorods (GNRs) are commercially available from many different 
suppliers (e.g., Aldrich, Nanopartz, and NanoSeeds). Most of these suppliers, 
along with academic researchers, use a wet-chemical seed-mediated approach 
to prepare GNRs. This implies the use of a high CTAB concentration as a shape-
directing agent. The major goal of this work is to prepare GNR at lower CTAB 
levels to: 1) increase GNR biocompatibility, 2) reduce the total cost of GNR 
production, 3) decrease the environmental impact, 4) improve understanding of 
the growth mechanism. 
 In these GNR synthesis experiments, a decrease in CTAB was coupled with 
an increase in KBr to keep the total concentration of bromide ions at 0.1 M in the 
growth solution. Figure 1 show Vis-NIR spectra comparing GNR’s absorbance 
profile when decreasing the concentration of CTAB without (Figure 6.1 A) and 
with (Figure 6.1 B) maintaining the bromide concentration via the addition of KBr. 
Figure 1A shows that reducing CTAB concentration from 0.1 M, the standard 
concentration, to 0.02 M CTAB, without compensating with KBr, resulted in 
shorter gold nanorods (seen as a blue shift in the absorbance peak). Gold 
nanospheres resulted when no CTAB was used (seen as a single absorbance 
peak). However, when reducing the CTAB concentration and compensating for 
missing bromide with KBr, GNR were formed with typical Vis-NIR spectra. Figure 
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6.1 clearly indicates the importance of keeping 0.1 M bromide as the 
concentration of total bromide ions to produce GNR and suggests that the high 
concentration of CTAB is not necessary when bromide concentration is 
maintained.   
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Figure 6.1. UV-Visible absorbance spectra of GNR prepared by decreasing 
CTAB concentration from 0.1 to 0 M, (A) without and (B) with the addition of KBr 
to maintain total bromide concentration at 0.1 M (from 0 to 0.1 M). Spectra are 
labeled by CTAB concentration (× 10-2 M CTAB). 
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 The formation of a CTAB bilayer on the surface of the as prepared GNR 
has been reported.5 The CTAB bilayer makes GNR positively charged, which 
stabilizes the GNR against aggregation via electrostatic repulsion. The stability of 
GNR against aggregation prepared using the standard method (0.1 M CTAB) 
and nanorods prepared via the greener method (0.02 M CTAB and 0.08 M KBr) 
was assessed using the centrifugation method. Vis-NIR spectra from each 
preparation are presented in Figure 6.2. The broadening and red shift of the 
longitudinal plasmon peak in the Vis-NIR spectra was used to assess the 
aggregation of the GNR. The stability in both cases against aggregation in 
response to repeated centrifugation and resuspension cycles was similar. 
Moreover, the effective surface charge of GNR in both cases, seen in zeta 
potential measurements, was also similar, about 40 mV. These results indicate 
that the reduction of CTAB to 20% of the standard concentration does not have 
an adverse effect on the stability of the prepared GNR. 
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Figure 6.2. UV-visible spectra of GNR suspensions prepared using (A) 0.1 M 
CTAB or (B) 0.02 M CTAB and 0.08 M KBr. Spectra are labeled by the number of 
centrifugation and resuspension cycles prior to collecting the data.  
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The wet-chemical seed-mediated approach produces GNRs with easily 
controlled and varied dimensions and optical properties. This is achieved in the 
standard protocol by varying the concentration of silver nitrate. Figure 6.3 shows 
UV-Vis spectra of GNR solutions prepared using 0.02 M CTAB and 0.08 M KBr 
where control over the aspect ratio of the GNR, and therefore their optical 
properties, was also achieved by varying the silver nitrate concentration, as 
confirmed by TEM (Figure 6.4). As a control experiment, varying the silver nitrate 
concentration, at a lower concentration of CTAB (0.02 M) without maintaining the 
bromide concentration at 0.1 M (i.e., no salt addition) resulted in only 
nanospheres being formed seen as a single absorbance peak in the Vis-NIR 
spectra (Figure 6.5). Images show red-colored solutions, which is characteristic 
to gold nanospheres. This important method of size control over GNR by varying 
the silver nitrate concentration still operates at a lower CTAB concentration, but 
only when total bromide is maintained at 0.1 M.  
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Figure 6.3. UV-visible spectra of the GNR suspensions prepared using 0.02 M 
CTAB and 0.08 M KBr with varying the silver nitrate concentration (0-0.2 mM) in 
the growth solution. Spectra and suspensions in the photograph are labeled by 
silver nitrate concentration (× 10-5 M AgNO3). 
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Figure 6.4. Transmission electron microscopy images of gold nanoparticles 
prepared using 0.02 M CTAB and 0.08 M KBr and varying silver nitrate 
concentrations: (A) 0 × 10-5 M, (B) 2 × 10-5 M, (C) 8 × 10-5 M, (D) 10 × 10-5 M. 
Inserts are photographs of the gold nanoparticle suspension illustrating their 
variation in appearance. 
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Figure 6.5. UV-visible spectra of GNR suspensions prepared using 0.02 M 
CTAB and zero salt with varying the silver nitrate concentration in the growth 
solution. Inset is a photograph of the GNR suspensions. Spectra and 
suspensions in the photograph are labeled by silver nitrate concentration (× 10-5 
M AgNO3). 
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The ionic strength of a solution is known to affect the micellar behavior of 
surfactants and promote a sphere-to-rod phase transition.16 To test the possibility 
of KBr as a means of increasing the ionic strength and thereby encouraging a 
soft-template mechanism, a synthesis of GNR at 0.02 M CTAB using 0.08 M KCl 
instead of KBr was performed. Interestingly, the Vis-NIR spectra of GNR 
suspensions produced using KCl with varying concentrations of silver nitrate 
(Figure 6.6) are atypical in shape, compared to the KBr synthesis (Figure 3), 
displaying broader, unsymmetrical peaks. Previous work has determined that this 
shape in the spectra is due to a mixture of gold nanoparticles with poor control 
over size and shape distribution.3  
 
 
 
 
 
 
 
 
 
 
 
 
 
	   177	  
 
 
 
Figure 6.6. UV-visible spectra of the GNR suspensions prepared using 0.02 M 
CTAB and 0.08 M KCl with varying the silver nitrate concentration in the growth 
solution. Spectra are labeled by silver nitrate concentration (× 10-5 M AgNO3). 
 
 
 
 
 
 
 
 
 
 
 
A
bs
or
ba
nc
e 
Wavelength (nm) 
	   178	  
Other salts, such as sodium chlorate and potassium nitrate, are known to 
induce a sphere-to-rod phase transition in CTAB micelles suspended in water.17 
In an effort to promote GNR formation by a soft-template method, GNRs were 
produced using 0.02 M CTAB, 0.08M KNO3 or sodium chlorate, and 10 × 10-5 M 
AgNO3. Vis-NIR spectra of these gold nanoparticle suspensions, along with a 
sample produced using KBr as a control sample, are presented in Figure 6.7. 
Both potassium nitrate and sodium chlorate resulted in a high fraction of spheres 
being produced as evident from a relatively large transverse plasmonic 
absorbance peak (left peak) compared to the longitudinal plasmonic absorbance 
peak (right peak).  
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Figure 6.7. UV-visible spectra of GNR suspensions prepared using 0.02 M 
CTAB, 10 × 10-5 M AgNO3, and 0.08 M of (A) KBr, (B) KNO3 or (C) sodium 
chlorate in the growth solution. 
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Collectively, these results indicate that the success of replacing 80% of 
the CTAB with potassium bromide is not simply due to a change in the ionic 
strength or the CTAB micellar behavior, since KCl, sodium chlorate, and KNO3 
did not form GNRs. These results demonstrate that bromide ions play a special 
role in promoting the formation of GNR, which agree with previously reported 
findings.12 Garg et al. proposed that bromide ions have etching effect on gold 
seeds to form a singe crystalline seed that preferentially elongates in one 
direction to form a GNR.18 Other reports suggested that Ag+ ions from silver 
nitrate and Br- ions from CTAB form AgBr/AgBr2- species, which preferentially 
adsorb to one crystal face of the gold seeds thereby promoting unidirectional 
growth to form GNR.5 Satybarata et al. reported that bromide ions act either to 
prevent or promote the formation of GNR depending on their concentration.19 
Smith et al. reported that impurities (iodide) in CTAB prevent GNR growth.20 
An important observation noted in this work is the effect of bromide ions 
on the reduction fate of Au3+ by ascorbic acid, the reducing agent employed in 
the standard preparation method. In the presence of bromide ions, either 0.1 M 
CTAB or KBr, gold solutions of 10-4 M chloroauric acid appear orange-yellow; 
while, in the presence of 0.1 M CTAC or water (negative control), gold solutions 
appear faint yellow to colorless (Figure 6.8). Upon the addition of ascorbic acid, 
gold solutions in the presence of bromide ions turned colorless indicating the 
reduction of Au3+ to Au1+. However, upon the addition of ascorbic acid, HAuCl4 
solutions in the presence of CTAC or pure water turned immediately to violet or 
dark red, respectively, indicating the formation of colloidal gold where Au3+ was 
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reduced to Au0. These observations indicate that the presence of bromide ions 
prevents the complete reduction of Au+3 to Au0 and thus the formation of 
spherical nanoparticles.  
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Figure 6.8. (A) Photographs showing the aqueous solution color of chloroauric 
acid in the presence of 0.1 M KBr, CTAB, CTAC, or water (negative control) 
before and after reduction with ascorbic acid. (B) UV-Vis spectra of the same 
solutions before reduction. 
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These results can be explained considering that Au3+ ions complex with 
bromide ions (from either CTAB or KBr) to form species that are more difficult to 
reduce. The standard redox potential values for the reduction of Au+3, [AuCl4]-, 
and [AuBr4]- to Au0 are shown in Table 6.1.21 Therefore, reduction is increasingly 
difficult in the order: Au3+ < [AuCl4]- < [AuBr4]-. To confirm the type of gold (III)-
halide complex ion in each solution, UV-Vis spectra were obtained before 
reducing with ascorbic acid. UV-Vis spectra of gold solutions in the presence of 
bromide ions, KBr and CTAB, show a clear peak around 381 nm and 389 nm, 
respectively. This is characteristic of the [AuBr4]- complex ion.22 However, UV-Vis 
spectra of chloroauric solutions in the presence of CTAC or pure water show a 
blue-shifted peak around 315 nm, which agrees with previously reported spectra 
for the [AuCl4]- complex ion in water.22 Collectively, these results indicate that 
bromide ions are necessary to prevent the spontaneous, aqueous-phase 
reduction of Au3+ to Au0 by ascorbic acid forming gold nanoparticles with poor 
shape control. Because of bromide ions, ascorbic acid is only capable of 
reducing Au3+ to Au1+ in the solution phase. In order to complete reduction to Au0 
in the presence of bromide ions, [AuBr4]- must complex with a surface, (i.e., a 
gold seed nanoparticle) thus resulting in a selective reduction by ascorbic acid at 
the surface of gold seeds to Au0.  
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Table 6.1. Standard redox potential values for the different ionic species 
investigated. pH of solutions   
Ionic species Redox potential (V) 
Au3+ (aq.) 
+ 3.11 
[AuCl4]- (aq.) 
+ 2.08 
[AuBr4]- (aq.) + 1.77 
 
From a mechanistic point of view, two mechanisms have been proposed 
to explain the formation of GNR in a micellar system. The first is a soft-template 
mechanism where CTAB molecules assemble in an aqueous system into rod-
shaped micelles confining the reduction of gold ions to the vicinity of these 
micelles resulting in rod-shaped gold nanoparticles. The second is a zipper 
mechanism where CTAB adsorbs preferentially on one facet of the seed 
nanocrystal leaving the other facet bare for one-directional growth to form GNR. 
These results support a zipper mechanism as evident from the ability to prepare 
GNR at a lower CTAB concentration by maintaining total bromide concentrations 
at 0.1 M by adding KBr. Cryo-TEM experiments were performed to determine the 
shape of CTAB micelles in the growth solution prior to seeding (Figure 6.9). In 
agreement with the literature, 0.1 M CTAB in pure water forms worm-like 
micelles, where the fist critical micelle concentration (cmc) is at about 1 mM and 
second cmc is at about 50 mM23 (Figure 6.9 A). However, the growth solution in 
the standard protocol contains additional chemicals (i.e., gold salt, silver nitrate, 
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and ascorbic acid) that may alter the micelle shape and its properties. 
Interestingly, Cryo-TEM images of growth solutions for the standard protocol (0.1 
M CTAB) show that CTAB micelles are globular, Figure 6.9 B-D. This is the first 
time that the micelle shape in the growth solution has been examined prior to 
adding the seed nanoparticles and provides further insight on the role of CTAB in 
the growth of GNR. These results demonstrate a significant difference in CTAB 
micellar shape in pure water versus the growth solution and support an 
adsorption / zipper mechanism over a soft-template mechanism for GNR 
formation since the CTAB do not form rod-shaped micelles in the presence of the 
additional chemicals used in the synthesis. 
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Figure 6.9. Cryo-TEM images of CTAB micelles at 0.1 M CTAB in (A) purified 
water and GNR growth solutions of 0.5 mM HAuCl4, 0.55 mM ascorbic acid, and 
(B) 0.5, (C) 5, or (D) 10 × 10-5 M AgNO3. All cryo TEM samples (B-D) were 
prepared from room temperature immediately after reduction with ascorbic acid 
and prior to adding seeds. 
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6.5 Conclusion 
In summary, stable GNR can be prepared with excellent size and shape 
control using only 20% of the CTAB concentration of the standard synthesis 
protocol by maintaining the bromide concentration at 0.1 M through addition of a 
simple bromide salt. Furthermore, these results indicate that the total CTAB 
concentration is not a key parameter in the formation of GNR, while the total 
concentration of bromide ions is critical to prevent complete reduction of Au3+ to 
Au0 forming spherical gold nanoparticles. Cryo-TEM imaging of the growth 
solution prior to seeding confirms the presence of spherical micelles, which 
provide visual evidence supporting an adsorption zipper mechanism over a soft-
template mechanism in the formation of GNR. Reducing the amount of CTAB 
used to produce GNR should decrease the total cost of GNR production and the 
amount of CTAB released into the environment. 
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